>pdb|7YVW|B Chain B, NMR determination of the 2:1 binding motif structure involving cytosine flipping out for the recognition of the CGG/CGG triad DNA
CATTCGGTTAG
>pdb|7YVW|A Chain A, NMR determination of the 2:1 binding motif structure involving cytosine flipping out for the recognition of the CGG/CGG triad DNA
CTAACGGAATG
>OO296052.1 Sequence 73 from patent US 11369689
GACAACTCTTT
>OO287209.1 Sequence 26 from patent US 11365226
TCCGCTAGGAA
>OO497814.1 Sequence 8 from patent US 11427867
TTGCCACAGTA
>OO497813.1 Sequence 7 from patent US 11427867
AACGGTGTCAT
>OO474301.1 Sequence 28 from patent US 11427819
TTCTAGTGAGC
>OO471848.1 Sequence 6 from patent US 11422832
ACTNNNNGATT
>OO471846.1 Sequence 4 from patent US 11422832
TCGNNNNGATT
>OO471844.1 Sequence 2 from patent US 11422832
CGCNNNNGATT
>OO470899.1 Sequence 10 from patent US 11421274
AAATTCCGGCA
>OO470898.1 Sequence 9 from patent US 11421274
GGATCAAGCTA
>OO470897.1 Sequence 8 from patent US 11421274
ATCCTTTAAGC
>OO470529.1 Sequence 51 from patent US 11421265
ACAGAAAGACA
>OO459219.1 Sequence 7 from patent US 11414784
CTACTCCTACC
>OO459217.1 Sequence 5 from patent US 11414784
AACCCAATCCC
>OO459216.1 Sequence 4 from patent US 11414784
ACGTGTCTACC
>OO459214.1 Sequence 2 from patent US 11414784
CGCCCGGACTC
>OO459160.1 Sequence 9 from patent US 11414714
CGTAGAGCCCA
>OO454702.1 Sequence 6 from patent US 11414653
ATTCGCTAGTG
>OO443667.1 Sequence 77 from patent US 11408004
CTCCTTCCTCC
>OO420341.1 Sequence 147 from patent US 11407990
TCGTAATTCCT
>OO420275.1 Sequence 73 from patent US 11407990
AGAGGGCTCTG
>OO416973.1 Sequence 23 from patent US 11406703
GGGATCCTACC
>OO411164.1 Sequence 2464 from patent US 11401346
CCTNNNNNAGG
>OO411161.1 Sequence 2461 from patent US 11401346
CGTCTCNNNNN
>OO411158.1 Sequence 2458 from patent US 11401346
CCANNNNNTGG
>OO411156.1 Sequence 2456 from patent US 11401346
GACNNNNNGTC
>OO411155.1 Sequence 2455 from patent US 11401346
GACNNNNNGTC
>OO411154.1 Sequence 2454 from patent US 11401346
NNNNNGAGACC
>OO411153.1 Sequence 2453 from patent US 11401346
GGTCTCNNNNN
>OO411152.1 Sequence 2452 from patent US 11401346
GCCNNNNNGGC
>OO411145.1 Sequence 2445 from patent US 11401346
GCANNNNNTGC
>OO410052.1 Sequence 636 from patent US 11400169
NNNNGAAGAGC
>OO410051.1 Sequence 635 from patent US 11400169
GCTCTTCNNNN
>OO410028.1 Sequence 608 from patent US 11400169
CCTNNNNNAGG
>OO410027.1 Sequence 607 from patent US 11400169
CGANNNNNTGG
>OO410026.1 Sequence 606 from patent US 11400169
CCANNNNNTCG
>OO410025.1 Sequence 605 from patent US 11400169
CCANNNNNTGG
>OO410024.1 Sequence 604 from patent US 11400169
GACNNNNNGTC
>OO410021.1 Sequence 601 from patent US 11400169
GACNNNNNTGA
>OO410020.1 Sequence 600 from patent US 11400169
GCNNNNNNNGC
>OO410017.1 Sequence 597 from patent US 11400169
AAGNNNNNCTT
>OO410016.1 Sequence 596 from patent US 11400169
GACNNNNNGTC
>OO410015.1 Sequence 595 from patent US 11400169
GACNNNNNGTC
>OO410014.1 Sequence 594 from patent US 11400169
GACNNNNNGTC
>OO410013.1 Sequence 593 from patent US 11400169
GAGNNNNNRTG
>OO410012.1 Sequence 592 from patent US 11400169
CAYNNNNNCTC
>OO410011.1 Sequence 591 from patent US 11400169
CAYNNNNNRTG
>OO410008.1 Sequence 588 from patent US 11400169
CCANNNNNNGT
>OO410007.1 Sequence 587 from patent US 11400169
GCNNNNNNNGC
>OO410006.1 Sequence 586 from patent US 11400169
CCTNNNNNAGG
>OO410005.1 Sequence 585 from patent US 11400169
CCNNNNNNNGG
>OO410004.1 Sequence 584 from patent US 11400169
CCNNNNNNNGG
>OO410003.1 Sequence 583 from patent US 11400169
CCNNNNNNNGG
>OO410000.1 Sequence 580 from patent US 11400169
GAGNNNNNCTC
>OO409999.1 Sequence 579 from patent US 11400169
GACNNNNNGTC
>OO409998.1 Sequence 578 from patent US 11400169
CCANNNNNTGG
>OO409997.1 Sequence 577 from patent US 11400169
GACNNNNNGTC
>OO409996.1 Sequence 576 from patent US 11400169
CCANNNNNTGG
>OO409971.1 Sequence 274 from patent US 11400169
NNNNNNGAAGG
>OO409970.1 Sequence 273 from patent US 11400169
CCTTCNNNNNN
>OO409952.1 Sequence 146 from patent US 11400169
ACNNNNNCTCC
>OO409949.1 Sequence 143 from patent US 11400169
ACNNNNGTAYC
>OO409948.1 Sequence 142 from patent US 11400169
NNNNGAAGAGC
>OO409947.1 Sequence 141 from patent US 11400169
GCTCTTCNNNN
>OO409946.1 Sequence 139 from patent US 11400169
NNNNGAAGAGC
>OO409945.1 Sequence 138 from patent US 11400169
GCTCTTCNNNN
>OO409928.1 Sequence 97 from patent US 11400169
NNNNNGAGACC
>OO409927.1 Sequence 96 from patent US 11400169
GGTCTCNNNNN
>OO409922.1 Sequence 88 from patent US 11400169
NNNNNCCCAGT
>OO409921.1 Sequence 87 from patent US 11400169
ACTGGGNNNNN
>OO409906.1 Sequence 61 from patent US 11400169
NNNNNNGAAGG
>OO409905.1 Sequence 60 from patent US 11400169
CCTTCNNNNNN
>OO409885.1 Sequence 22 from patent US 11400169
NNNNNNNGAGG
>OO409884.1 Sequence 21 from patent US 11400169
CCTCNNNNNNN
>OO408410.1 Sequence 5686 from patent US 11400144
GAGCTAATAAA
>OO408384.1 Sequence 5660 from patent US 11400144
TTTACTTCCTC
>OO408215.1 Sequence 5484 from patent US 11400144
TTATAACACCT
>OO408090.1 Sequence 5352 from patent US 11400144
TAGGATAAGAA
>OO407924.1 Sequence 5174 from patent US 11400144
GAATAGCTATC
>OO407837.1 Sequence 5084 from patent US 11400144
TATATCTACTC
>OO407707.1 Sequence 4949 from patent US 11400144
ATTATTTGAGC
>OO407539.1 Sequence 4772 from patent US 11400144
ATTTTCACAAC
>OO407460.1 Sequence 4692 from patent US 11400144
GATTATCACCT
>OO407367.1 Sequence 4596 from patent US 11400144
AAAATTCCTCC
>OO407301.1 Sequence 4526 from patent US 11400144
AATATTCCTCC
>OO407177.1 Sequence 4398 from patent US 11400144
CCGTGATTAAT
>OO407004.1 Sequence 4221 from patent US 11400144
GGTGATTAACT
>OO406966.1 Sequence 4182 from patent US 11400144
GCGGTGGTATC
>OO406965.1 Sequence 4181 from patent US 11400144
GAGGAATTGAC
>OO406764.1 Sequence 3969 from patent US 11400144
GAGGATGAATT
>OO406746.1 Sequence 3950 from patent US 11400144
AATTGGAAGAT
>OO406649.1 Sequence 3848 from patent US 11400144
AATTAATTAAA
>OO406579.1 Sequence 3775 from patent US 11400144
AGGGTGAAAAT
>OO406544.1 Sequence 3738 from patent US 11400144
AAGCTTGTAGC
>OO406503.1 Sequence 3696 from patent US 11400144
CTTATTTTCAC
>OO406417.1 Sequence 3606 from patent US 11400144
ATTTATTATTT
>OO406412.1 Sequence 3601 from patent US 11400144
GAGTGTTTAGT
>OO406380.1 Sequence 3567 from patent US 11400144
TTTTGATTTGT
>OO406369.1 Sequence 3556 from patent US 11400144
TTTTGATTTGT
>OO406324.1 Sequence 3508 from patent US 11400144
AAAATTAGAAC
>OO406317.1 Sequence 3499 from patent US 11400144
GAGTTGAATAT
>OO406315.1 Sequence 3495 from patent US 11400144
GGAGAATTTTT
>OO406304.1 Sequence 3483 from patent US 11400144
AAGGTGAGAAT
>OO406228.1 Sequence 3395 from patent US 11400144
AATAAAATTTT
>OO406172.1 Sequence 3338 from patent US 11400144
TTGTGAATCAG
>OO406116.1 Sequence 3280 from patent US 11400144
TTCGACCAATT
>OO405920.1 Sequence 3078 from patent US 11400144
GATTTTTAATC
>OO405723.1 Sequence 2881 from patent US 11400144
TAGTGAAACTA
>OO405693.1 Sequence 2851 from patent US 11400144
CTCTTTTAGAG
>OO405581.1 Sequence 2739 from patent US 11400144
TTTTATAAAAA
>OO405447.1 Sequence 2605 from patent US 11400144
TTAAAATTTAA
>OO405299.1 Sequence 2457 from patent US 11400144
TTTATCATAAA
>OO405083.1 Sequence 2241 from patent US 11400144
TTTATTTTAAA
>OO404998.1 Sequence 2156 from patent US 11400144
CTTTTAAAAAG
>OO404844.1 Sequence 2002 from patent US 11400144
TATTTTTAATA
>OO404834.1 Sequence 1992 from patent US 11400144
CTATGGAATAG
>OO404830.1 Sequence 1988 from patent US 11400144
TCCTTAAAGGG
>OO404714.1 Sequence 1872 from patent US 11400144
TAGTTTTACTA
>OO404674.1 Sequence 1832 from patent US 11400144
GATTTACAATC
>OO402674.1 Sequence 39 from patent US 11400110
GTTTTTGTACT
>OO402667.1 Sequence 25 from patent US 11400110
AATCATTTGAG
>OO402666.1 Sequence 24 from patent US 11400110
TTTCATTTGAG
>OO267896.1 Sequence 23 from patent US 11352675
ATACCACCCCC
>OO267877.1 Sequence 4 from patent US 11352675
GCGCATCGTCG
>OO267658.1 Sequence 1294 from patent US 11352666
CGGTGGGTGCC
>OO260264.1 Sequence 103 from patent US 11352630
AAGANNNTCTT
>OO260164.1 Sequence 2 from patent US 11352630
NGNTAATANCN
>OO259036.1 Sequence 31 from patent US 11352611
CAACGGACCTC
>OO259034.1 Sequence 28 from patent US 11352611
CAACGGACCTC
>OO256773.1 Sequence 54 from patent US 11351271
TTCANGAGACC
>OO256772.1 Sequence 53 from patent US 11351271
GGTCTCNATAA
>OO256769.1 Sequence 50 from patent US 11351271
GCTCTTCNATA
>OO256766.1 Sequence 47 from patent US 11351271
ATAANGAGACC
>OO256765.1 Sequence 46 from patent US 11351271
GGTCTCNCACC
>OO256764.1 Sequence 45 from patent US 11351271
ATAAGAAGAGC
>OO256760.1 Sequence 41 from patent US 11351271
CACCNGAGACC
>OO256759.1 Sequence 40 from patent US 11351271
GGTCTCNGACT
>OO256758.1 Sequence 39 from patent US 11351271
CACNGAAGAGC
>OO256757.1 Sequence 38 from patent US 11351271
GCTCTTCNACT
>OO256362.1 Sequence 18 from patent US 11351242
GGGATCCTACC
>OO240606.1 Sequence 36 from patent US 11344633
GCGGTTTGCGG
>OO240592.1 Sequence 20 from patent US 11344633
GGTGGTGGTGG
>OO230852.1 Sequence 79 from patent US 11339392
TAGCATACTTA
>OO230851.1 Sequence 78 from patent US 11339392
TGGCCATCAAT
>OO230850.1 Sequence 77 from patent US 11339392
ACCAAAAGAAT
>OO230844.1 Sequence 69 from patent US 11339392
TAGCATACTTA
>OO230843.1 Sequence 68 from patent US 11339392
TGGCCATCAAT
>OO230842.1 Sequence 67 from patent US 11339392
ACCAAAAGAAT
>OO230830.1 Sequence 55 from patent US 11339392
TAGCATACTTA
>OO230829.1 Sequence 54 from patent US 11339392
TGGCCATCAAT
>OO230828.1 Sequence 53 from patent US 11339392
ACCAAAAGAAT
>OO230824.1 Sequence 47 from patent US 11339392
TAGCATACTTA
>OO230823.1 Sequence 46 from patent US 11339392
TGGCCATCAAT
>OO230822.1 Sequence 45 from patent US 11339392
ACCAAAAGAAT
>OO230615.1 Sequence 25 from patent US 11339388
CTACTCCTACC
>OO230613.1 Sequence 23 from patent US 11339388
AACCCAATCCC
>OO230612.1 Sequence 22 from patent US 11339388
ACGTGTCTACC
>OO230610.1 Sequence 20 from patent US 11339388
CGCCCGGACTC
>OO184029.1 Sequence 2 from patent US 11335437
ATCGTGGTAAT
>OO173304.1 Sequence 3 from patent US 11332737
TGCATGATACG
>OO162995.1 Sequence 116 from patent US 11326165
GGAGTAAGTCT
>OO162994.1 Sequence 115 from patent US 11326165
ATACTTACCTG
>OO162953.1 Sequence 74 from patent US 11326165
GAGGTGGGTTT
>OO162930.1 Sequence 51 from patent US 11326165
GAGGTGGGTTT
>OO162928.1 Sequence 49 from patent US 11326165
CTGGTGAGTTC
>OO162922.1 Sequence 43 from patent US 11326165
CAGGTGAGTGG
>OO162917.1 Sequence 38 from patent US 11326165
CAGGTAGGTGA
>OO162916.1 Sequence 37 from patent US 11326165
CAGGTAGGAGG
>OO162910.1 Sequence 31 from patent US 11326165
CAGGTAACCTC
>OO162905.1 Sequence 26 from patent US 11326165
AGTGTGAGTAC
>OO162896.1 Sequence 17 from patent US 11326165
AAGGTGACCTT
>OO162892.1 Sequence 13 from patent US 11326165
AAGGTAATGTA
>OO162887.1 Sequence 8 from patent US 11326165
AAGGTAACATG
>OO401947.1 Sequence 168 from patent US 11396664
GGGCCACTAGT
>OO401946.1 Sequence 167 from patent US 11396664
ATCCTATATAA
>OO350706.1 Sequence 9 from patent US 11393558
ACTGCTCTAGA
>OO350705.1 Sequence 8 from patent US 11393558
TACTGCTCTAG
>OO350704.1 Sequence 7 from patent US 11393558
CTAGAGCAGTA
>OO350703.1 Sequence 6 from patent US 11393558
TCTAGAGCAGT
>OO346618.1 Sequence 112 from patent US 11390865
CTACCAAGACG
>OO345173.1 Sequence 37 from patent US 11389525
TGACTAGTTAA
>OO340884.1 Sequence 49 from patent US 11384364
GCCNCCATGGC
>OO340883.1 Sequence 47 from patent US 11384364
CCAGGTATGGC
>OO340882.1 Sequence 46 from patent US 11384364
GTAGTCATGTC
>OO340881.1 Sequence 45 from patent US 11384364
TCTTTTATGGC
>OO340880.1 Sequence 44 from patent US 11384364
TGTTTTATGGC
>OO340879.1 Sequence 43 from patent US 11384364
TAGTTTATGGC
>OO340878.1 Sequence 42 from patent US 11384364
TAGTGTATGGC
>OO340877.1 Sequence 41 from patent US 11384364
TCTTTTATGGG
>OO340876.1 Sequence 40 from patent US 11384364
TGTTTTATGGG
>OO340875.1 Sequence 39 from patent US 11384364
TAGTTTATGGG
>OO340874.1 Sequence 38 from patent US 11384364
TAGTGTATGGG
>OO340873.1 Sequence 37 from patent US 11384364
TCTTTTATGTC
>OO340872.1 Sequence 36 from patent US 11384364
TGTTTTATGTC
>OO340871.1 Sequence 35 from patent US 11384364
TAGTTTATGTC
>OO340870.1 Sequence 34 from patent US 11384364
TAGTGTATGTC
>OO340869.1 Sequence 33 from patent US 11384364
TNNTNTATGNN
>OO340868.1 Sequence 32 from patent US 11384364
TAGTTTATGTC
>OO340867.1 Sequence 31 from patent US 11384364
TAGTGTATGTC
>OO340866.1 Sequence 30 from patent US 11384364
TCTTTTATGGG
>OO340865.1 Sequence 29 from patent US 11384364
TGTTTTATGGG
>OO340864.1 Sequence 28 from patent US 11384364
TAGTTTATGGG
>OO340863.1 Sequence 27 from patent US 11384364
TAGTGTATGGG
>OO340862.1 Sequence 26 from patent US 11384364
TCTTTTATGTC
>OO340861.1 Sequence 25 from patent US 11384364
TGTTTTATGTC
>OO340860.1 Sequence 24 from patent US 11384364
TAGTTTATGTC
>OO340859.1 Sequence 23 from patent US 11384364
TAGTGTATGTC
>OO340858.1 Sequence 22 from patent US 11384364
CATTTTATGGG
>OO340857.1 Sequence 21 from patent US 11384364
ACTTGTATGGG
>OO340856.1 Sequence 20 from patent US 11384364
CCGTTTATGGG
>OO340855.1 Sequence 19 from patent US 11384364
CATTGTATGGC
>OO340854.1 Sequence 18 from patent US 11384364
TATTGTATGGC
>OO340853.1 Sequence 17 from patent US 11384364
TAGTGTATGGC
>OO340852.1 Sequence 16 from patent US 11384364
CAGTGTATGGC
>OO340851.1 Sequence 15 from patent US 11384364
TAGTTTATGGC
>OO340850.1 Sequence 14 from patent US 11384364
TGGTATATGGC
>OO340849.1 Sequence 13 from patent US 11384364
TAGCGCATGGC
>OO340848.1 Sequence 12 from patent US 11384364
NNNNNNATGNN
>OO340847.1 Sequence 11 from patent US 11384364
TAGTGTATGTC
>OO340846.1 Sequence 10 from patent US 11384364
TAGTTTATGTC
>OO340845.1 Sequence 9 from patent US 11384364
TGTTTTATGTC
>OO340844.1 Sequence 8 from patent US 11384364
TCTTTTATGTC
>OO340843.1 Sequence 7 from patent US 11384364
CATTGTATGCT
>OO340842.1 Sequence 6 from patent US 11384364
TAGTGTATGCT
>OO340841.1 Sequence 5 from patent US 11384364
CATTGTATGGT
>OO340840.1 Sequence 4 from patent US 11384364
CAGTTTATGGT
>OO340839.1 Sequence 3 from patent US 11384364
TCGTTTATGGA
>OO340838.1 Sequence 2 from patent US 11384364
CATTGTATGTC
>OO340837.1 Sequence 1 from patent US 11384364
NNNTNTATGNN
>OO340801.1 Sequence 2 from patent US 11384363
CTAANTGGGGA
>OO340800.1 Sequence 1 from patent US 11384363
CTAACTGGGGA
>OO340468.1 Sequence 406 from patent US 11384361
AACACACAGAG
>OO340465.1 Sequence 403 from patent US 11384361
ATTCAACACAC
>OO340459.1 Sequence 397 from patent US 11384361
AACACACAGAG
>OO340458.1 Sequence 396 from patent US 11384361
TCAACACACAG
>OO340453.1 Sequence 391 from patent US 11384361
AACACACAGAG
>OO339579.1 Sequence 85 from patent US 11384355
GACCATCGAAT
>OO339576.1 Sequence 81 from patent US 11384355
CCAAGTTCCAT
>OO339569.1 Sequence 74 from patent US 11384355
TATGGCTGTGC
>OO339542.1 Sequence 45 from patent US 11384355
GACCATCGAAT
>OO339539.1 Sequence 41 from patent US 11384355
CCAAGTTCCAT
>OO339533.1 Sequence 35 from patent US 11384355
TATGGCTGTGC
>OO337998.1 Sequence 57 from patent US 11384344
GGGAACCCTCC
>OO337953.1 Sequence 12 from patent US 11384344
GGGAACCCTCC
>OO337594.1 Sequence 4 from patent US 11384335
TGCCTACTGCC
>OO337592.1 Sequence 2 from patent US 11384335
GACAGTGAGCG
>OO336638.1 Sequence 56 from patent US 11382974
CCGCCRCCAGG
>OO336635.1 Sequence 50 from patent US 11382974
CCGCCRCCAGG
>OO335547.1 Sequence 16 from patent US 11377696
ATGAGAGTCCT
>OO335546.1 Sequence 15 from patent US 11377696
ATGAGAGTCCT
>OO335541.1 Sequence 10 from patent US 11377696
ATGAGAGTCCT
>OO335540.1 Sequence 9 from patent US 11377696
ATGAGAGTCCT
>OO332146.1 Sequence 56 from patent US 11377688
CAAAGGNANAG
>OO303584.1 Sequence 252 from patent US 11371101
GCCCCAGGACG
>OO303539.1 Sequence 207 from patent US 11371101
TGGGAGCCCTG
>OO303398.1 Sequence 66 from patent US 11371101
AGCAGCTCGAA
>OO303115.1 Sequence 90 from patent US 11371084
CTGTGTGTGTG
>OO301644.1 Sequence 38 from patent US 11371052
GTGTGAGGCGC
>OO301426.1 Sequence 65 from patent US 11371050
GAGGAAGAGGN
>OO301424.1 Sequence 63 from patent US 11371050
ACGGGACTGTN
>OO300349.1 Sequence 232 from patent US 11371031
TTTTTTTTTTT
>OO300230.1 Sequence 16 from patent US 11371027
GCCGTATCCCT
>OO300229.1 Sequence 15 from patent US 11371027
CGCGCTGTTAT
>OO300228.1 Sequence 14 from patent US 11371027
CGCGCTGTTAT
>OO294072.1 Sequence 4 from patent US 11365437
GGGATCCTACC
>OO278870.1 Sequence 6 from patent US 11359234
ACTNNNNGATT
>OO278868.1 Sequence 4 from patent US 11359234
TCGNNNNGATT
>OO278866.1 Sequence 2 from patent US 11359234
CGCNNNNGATT
>OO150069.1 Sequence 1 from patent US 11319592
CCCCTTCCGGG
>OO149376.1 Sequence 39 from patent US 11319555
AATTCCTCTGA
>OO148871.1 Sequence 104 from patent US 11319549
GTCTAATTATT
>OO095271.1 Sequence 104 from patent US 11312965
TCGAACGTTCG
>OO077994.1 Sequence 5 from patent US 11312754
GTGACTCAGCA
>pdb|8FOJ|T Chain T, Cryo-EM structure of S. cerevisiae DNA polymerase alpha-primase complex in the post RNA handoff state
NCTGCCCGCCT
>pdb|8G5Z|mR Chain mR, mRNA decoding in human is kinetically and structurally distinct from bacteria (GA state)
NGTATGTTCAA
>pdb|8BTR|y Chain y, Giardia Ribosome in PRE-T Hybrid State (D2)
NAAATGGAGAA
>pdb|8BTD|y Chain y, Giardia Ribosome in PRE-T Hybrid State (D1)
NAAATGGAGAA
>pdb|8BSJ|y Chain y, Giardia Ribosome in PRE-T Classical State (C)
NAAATGGATAA
>pdb|8BSI|y Chain y, Giardia ribosome chimeric hybrid-like GDP+Pi bound state (B1)
NAAATGGATAA
>pdb|8DW7|F Chain F, DNA glycosylase MutY variant N146S in complex with DNA containing the transition state analog 1N paired with d(8-oxo-G)
TGTCCANGTCT
>pdb|8DW7|E Chain E, DNA glycosylase MutY variant N146S in complex with DNA containing the transition state analog 1N paired with d(8-oxo-G)
AAGACNTGGAC
>pdb|8DW7|C Chain C, DNA glycosylase MutY variant N146S in complex with DNA containing the transition state analog 1N paired with d(8-oxo-G)
TGTCCANGTCT
>pdb|8DW7|B Chain B, DNA glycosylase MutY variant N146S in complex with DNA containing the transition state analog 1N paired with d(8-oxo-G)
AAGACNTGGAC
>pdb|8DW4|C Chain C, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an abasic site product (AP) generated by the enzyme in crystals by removal of calcium
TGTCCANGTCT
>pdb|8DW4|B Chain B, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an abasic site product (AP) generated by the enzyme in crystals by removal of calcium
AAGACNTGGAC
>pdb|8DW0|C Chain C, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an enzyme-generated abasic site (AP) product and crystallized with sodium acetate
TGTCCANGTCT
>pdb|8DW0|B Chain B, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an enzyme-generated abasic site (AP) product and crystallized with sodium acetate
AAGACNTGGAC
>pdb|8DVY|C Chain C, DNA glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an enzyme-generated abasic site product (AP) and crystalized with calcium acetate
TGTCCANGTCT
>pdb|8DVY|B Chain B, DNA glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with an enzyme-generated abasic site product (AP) and crystalized with calcium acetate
AAGACNTGGAC
>pdb|8DVP|C Chain C, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with substrate purine
TGTCCANGTCT
>pdb|8DVP|B Chain B, Glycosylase MutY variant N146S in complex with DNA containing d(8-oxo-G) paired with substrate purine
AAGACNTGGAC
>PA573453.1 WO 2023277168-A/433: Polynucleotide and pharmaceutical composition
CAGCCACCATG
>pdb|7UR0|F Chain F, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold-insert duplexes (21mer and 10mer) containing the cognate REPE54 sequence and an additional T-A rich sequence, respectively.
AGTAATTACCG
>pdb|7UR0|E Chain E, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold-insert duplexes (21mer and 10mer) containing the cognate REPE54 sequence and an additional T-A rich sequence, respectively.
AGACGGTAATT
>pdb|7SD8|B Chain B, [U:Hg2+:U] Metal-mediated DNA base pair in a self-assembling rhombohedral lattice
NCANACANACA
>pdb|1BMV|M Chain M, PROTEIN-RNA INTERACTIONS IN AN ICOSAHEDRAL VIRUS AT 3.0 ANGSTROMS RESOLUTION
NGTCAAAATGC
>pdb|1MVM|B Chain B, MVM(STRAIN I), COMPLEX(VIRAL COAT/DNA), VP2, PH=7.5, T=4 DEGREES C
NCACCCCAACA
>pdb|4DPV|N Chain N, PARVOVIRUS/DNA COMPLEX
NTACCTCTTGC
>OO074501.1 Sequence 66 from patent US 11306355
TCGACNGGATC
>OO074500.1 Sequence 65 from patent US 11306355
TCGACNGGATC
>OO074499.1 Sequence 64 from patent US 11306355
TCGACNGGATC
>OO074498.1 Sequence 63 from patent US 11306355
TCGACNGGATC
>OO074497.1 Sequence 62 from patent US 11306355
TCGACNGGATC
>OO074496.1 Sequence 61 from patent US 11306355
TCGACNGGATC
>OO074495.1 Sequence 60 from patent US 11306355
TCGACNGGATC
>OO074494.1 Sequence 59 from patent US 11306355
TCGACNGGATC
>OO074490.1 Sequence 55 from patent US 11306355
TCGACNGGATC
>OO074489.1 Sequence 54 from patent US 11306355
TCGACNGGATC
>OO067055.1 Sequence 55 from patent US 11305282
AGCGATAGTAC
>OO064716.1 Sequence 1 from patent US 11299777
GGCTTATGGAG
>OO064547.1 Sequence 3 from patent US 11299770
NAACNAACAAN
>OO064543.1 Sequence 14 from patent US 11299769
GGCCCGGGCCG
>OO063081.1 Sequence 18 from patent US 11299735
CNCACCNGGAG
>OO063074.1 Sequence 8 from patent US 11299735
NCACCNGGAGC
>OO061858.1 Sequence 10 from patent US 11299511
GTGGAAGGCGG
>OO061852.1 Sequence 4 from patent US 11299511
GTTAGGGTTAG
>OO061850.1 Sequence 2 from patent US 11299511
CTAACCCTAAC
>OO004297.1 Sequence 37 from patent US 11293024
ATCGTTGCATC
>OO004296.1 Sequence 36 from patent US 11293024
TCTCAGATGGT
>OO004295.1 Sequence 35 from patent US 11293024
CTCATACCTTG
>OO004294.1 Sequence 22 from patent US 11293024
GTCGAACCAAT
>OO004293.1 Sequence 21 from patent US 11293024
GCAAAGTCCTC
>OO004292.1 Sequence 20 from patent US 11293024
ACCTCCCAGGC
>OO004291.1 Sequence 19 from patent US 11293024
ATGTCCATCAT
>OO004290.1 Sequence 18 from patent US 11293024
CTAGCACTCCC
>OO004289.1 Sequence 17 from patent US 11293024
AGGCTCATAGG
>OO004288.1 Sequence 16 from patent US 11293024
CAGTCGCCCCT
>OO004287.1 Sequence 15 from patent US 11293024
AGAATTCTCAT
>OO004286.1 Sequence 14 from patent US 11293024
GTACGGTTCAT
>OO004285.1 Sequence 13 from patent US 11293024
GCATTTGACCT
>OO004284.1 Sequence 12 from patent US 11293024
GCCAGGGTCAT
>OO004283.1 Sequence 11 from patent US 11293024
TAATCCGTCAG
>OO004282.1 Sequence 10 from patent US 11293024
ATCAAACTCAT
>OO004281.1 Sequence 9 from patent US 11293024
AGGCTTCCGTC
>OO004280.1 Sequence 8 from patent US 11293024
CCACCTCCAGG
>OO004279.1 Sequence 7 from patent US 11293024
TGACTCTCCTC
>OO004278.1 Sequence 6 from patent US 11293024
AGCACCCTCAT
>OO004277.1 Sequence 5 from patent US 11293024
CTCTAGACATG
>OO004276.1 Sequence 4 from patent US 11293024
CATACCTTGTT
>OO004275.1 Sequence 3 from patent US 11293024
TTCTCTCCTTT
>OO004274.1 Sequence 2 from patent US 11293024
GTTGTTTGATC
>OO004273.1 Sequence 1 from patent US 11293024
CCTCAGACTCC
>OO004172.1 Sequence 1 from patent US 11293020
AAACAAACAAA
>MY998620.1 Sequence 8 from patent US 11286532
AAAGAAACAAA
>MY946492.1 Sequence 38 from patent US 11286482
CAGGTAAGTAT
>MY944936.1 Sequence 4 from patent US 11281856
TAAATCTGGGG
>MY944789.1 Sequence 10 from patent US 11279979
TGCACATCATG
>MY944787.1 Sequence 8 from patent US 11279979
AATGATGCACG
>MY944784.1 Sequence 5 from patent US 11279979
CTGATCAGTGA
>MY943615.1 Sequence 36 from patent US 11279939
TGGAAAACTCC
>MY943614.1 Sequence 35 from patent US 11279939
GGAGTTTTCCA
>MY943613.1 Sequence 34 from patent US 11279939
TGGAAAAACAC
>MY943612.1 Sequence 33 from patent US 11279939
TGGAAATCTCC
>MY943611.1 Sequence 32 from patent US 11279939
TGGAAAATTTT
>MY943610.1 Sequence 31 from patent US 11279939
TGGAAAGTTTT
>MY943609.1 Sequence 30 from patent US 11279939
TGGAAAGTTCC
>MY943608.1 Sequence 29 from patent US 11279939
TGGAAAGTTAC
>MY943607.1 Sequence 28 from patent US 11279939
TGGAAAATTAC
>MY943605.1 Sequence 26 from patent US 11279939
TGGAATTCTAT
>MY943604.1 Sequence 25 from patent US 11279939
ATAGAATTCCA
>MY943603.1 Sequence 24 from patent US 11279939
TGGAAAACTAC
>MY943602.1 Sequence 23 from patent US 11279939
CGGAAAATCCC
>MY943601.1 Sequence 22 from patent US 11279939
CGGAAAATACC
>MY943600.1 Sequence 21 from patent US 11279939
CGGAAAAAACC
>MY943599.1 Sequence 20 from patent US 11279939
AGGAAAATCAC
>MY943598.1 Sequence 19 from patent US 11279939
TGGAAATTTAC
>MY943597.1 Sequence 18 from patent US 11279939
TGGAATATTAC
>MY943596.1 Sequence 17 from patent US 11279939
TGGAAAATTAC
>MY943595.1 Sequence 16 from patent US 11279939
TGGAAAATCAC
>MY943594.1 Sequence 15 from patent US 11279939
CGGAAAATCAC
>MY943593.1 Sequence 14 from patent US 11279939
TGGAAAATCAC
>MY943592.1 Sequence 13 from patent US 11279939
TGGAAAAATTT
>MY943591.1 Sequence 12 from patent US 11279939
TGGAAAAATAT
>MY943590.1 Sequence 11 from patent US 11279939
TGGAAAAGTCC
>MY943588.1 Sequence 9 from patent US 11279939
TGGAAAATCAC
>MY943585.1 Sequence 5 from patent US 11279939
TGGAAATTTGT
>MY943584.1 Sequence 4 from patent US 11279939
HGGAAANNHNH
>MY943583.1 Sequence 1 from patent US 11279939
HGGAAWNNHNH
>MY935903.1 Sequence 461 from patent US 11278571
GRTVDGTVVSD
>MY929996.1 Sequence 2 from patent US 11275081
ATATATGTAAG
>MY929824.1 Sequence 1339 from patent US 11274350
CCATCCTTGTC
>MY929822.1 Sequence 1337 from patent US 11274350
GAGGAGGCAGT
>MY928468.1 Sequence 1 from patent US 11274335
TCGACCGGATC
>MY916596.1 Sequence 1 from patent US 11274317
TTCACTTATTC
>MY915217.1 Sequence 120 from patent US 11274294
GGTCTCNCCTG
>MY915216.1 Sequence 119 from patent US 11274294
AGCANGAGACC
>MY915215.1 Sequence 118 from patent US 11274294
CAGGNGAGACC
>MY915214.1 Sequence 117 from patent US 11274294
GGTCTCNTGCT
>MY915213.1 Sequence 116 from patent US 11274294
CCTGTGAGACC
>MY915212.1 Sequence 115 from patent US 11274294
GGTCTCAAGCA
>MY915211.1 Sequence 114 from patent US 11274294
GGTCTCACAGG
>MY915210.1 Sequence 113 from patent US 11274294
TGCTTGAGACC
>MY914482.1 Sequence 16 from patent US 11274134
CTGGGGATTTA
>MY914480.1 Sequence 14 from patent US 11274134
AGGGGGATCTG
>MY914479.1 Sequence 13 from patent US 11274134
GGGGACTTTCC
>MY914478.1 Sequence 12 from patent US 11274134
GGGGAATCCCC
>MY914473.1 Sequence 7 from patent US 11274134
RGGRNNHHYYB
>MY914101.1 Sequence 178 from patent US 11273442
TTTTTTTTTTT
>MY913397.1 Sequence 188 from patent US 11268159
CTTGCCCAGGC
>MY911718.1 Sequence 20 from patent US 11268144
CAATCCCAATC
>MY911491.1 Sequence 8 from patent US 11268136
GGTGGGGGTGG
>MY910860.1 Sequence 3 from patent US 11268115
ATCGGATCCAT
>MY901735.1 Sequence 10 from patent US 11266672
AGAAATATTGT
>MY901729.1 Sequence 1334 from patent US 11266655
GTTACAATGAG
>MY901493.1 Sequence 1098 from patent US 11266655
RSCGGWAATKR
>MY901492.1 Sequence 1097 from patent US 11266655
RSCGGWAATKR
>MY901336.1 Sequence 941 from patent US 11266655
RGAATGYGTGA
>MY901320.1 Sequence 925 from patent US 11266655
NYNATMAATCA
>MY901307.1 Sequence 912 from patent US 11266655
WAACAACACMY
>MY901298.1 Sequence 903 from patent US 11266655
RSCGGTAATKR
>MY901260.1 Sequence 865 from patent US 11266655
NTCGTAAATCA
>MY901115.1 Sequence 720 from patent US 11266655
ACCGGAAATGA
>MY901092.1 Sequence 697 from patent US 11266655
YMTGTMTYTAW
>MY901090.1 Sequence 695 from patent US 11266655
WRWRTMAAYAW
>MY901089.1 Sequence 694 from patent US 11266655
WRWGTMAAYAN
>MY901067.1 Sequence 672 from patent US 11266655
NGYAATWAAAN
>MY901066.1 Sequence 671 from patent US 11266655
NGYAATWAAAN
>MY901048.1 Sequence 653 from patent US 11266655
RTGTAYGGRTG
>MY901009.1 Sequence 614 from patent US 11266655
NTATGCWAATN
>MY900995.1 Sequence 600 from patent US 11266655
NSCCNNNGGSN
>MY900994.1 Sequence 599 from patent US 11266655
NSCCNNNGGSN
>MY900993.1 Sequence 598 from patent US 11266655
NSCCNNNGGSN
>MY900975.1 Sequence 580 from patent US 11266655
NNCAMTTAANN
>MY900974.1 Sequence 579 from patent US 11266655
NNCAMTTAANN
>MY900973.1 Sequence 578 from patent US 11266655
NNCAMTTAANN
>MY900965.1 Sequence 570 from patent US 11266655
NGTCGTWAAAN
>MY900949.1 Sequence 554 from patent US 11266655
NATGASTCATN
>MY900926.1 Sequence 531 from patent US 11266655
TGRTAGCGCCR
>MY900923.1 Sequence 528 from patent US 11266655
YGGCGCTAYCA
>MY900918.1 Sequence 523 from patent US 11266655
RTAAAYAAACA
>MY900898.1 Sequence 503 from patent US 11266655
NCCGCCATNNT
>MY900873.1 Sequence 478 from patent US 11266655
NTCAAGGTCAN
>MY900865.1 Sequence 470 from patent US 11266655
NRGATAATCYN
>MY900860.1 Sequence 465 from patent US 11266655
NNYTAATTANN
>MY900825.1 Sequence 430 from patent US 11266655
NNNNTGCTGAN
>MY900816.1 Sequence 421 from patent US 11266655
NNCCGCCATNW
>MY900801.1 Sequence 406 from patent US 11266655
NNAACCGTTNN
>MY900800.1 Sequence 405 from patent US 11266655
NNAACCGTTNN
>MY900795.1 Sequence 400 from patent US 11266655
NGTCGTAAAAN
>MY900794.1 Sequence 399 from patent US 11266655
NGTCGTAAAAN
>MY900789.1 Sequence 394 from patent US 11266655
NCTCGTAAAAN
>MY900788.1 Sequence 393 from patent US 11266655
NCTCGTAAAAN
>MY900787.1 Sequence 392 from patent US 11266655
NCTCGTAAAAN
>MY900786.1 Sequence 391 from patent US 11266655
NCTCGTAAAAN
>MY900780.1 Sequence 385 from patent US 11266655
NCCGCCATTNN
>MY900778.1 Sequence 383 from patent US 11266655
NATGCGGGTAN
>MY900774.1 Sequence 379 from patent US 11266655
NAGGTGTGAWN
>MY900773.1 Sequence 378 from patent US 11266655
NAGGTGTGAAN
>MY900772.1 Sequence 377 from patent US 11266655
NAGGTGTGAAN
>MY900769.1 Sequence 374 from patent US 11266655
NACCGAAACYN
>MY900743.1 Sequence 348 from patent US 11266655
NNGCGGAAGTG
>MY900736.1 Sequence 341 from patent US 11266655
MCGCCCACGCA
>MY900730.1 Sequence 335 from patent US 11266655
ACCYTMARGGT
>MY900721.1 Sequence 326 from patent US 11266655
TGMATWWWTNA
>MY900683.1 Sequence 288 from patent US 11266655
GCCMCGCCCMC
>MY900682.1 Sequence 287 from patent US 11266655
GCCMCGCCCMC
>MY900681.1 Sequence 286 from patent US 11266655
GCCMCGCCCMC
>MY900637.1 Sequence 242 from patent US 11266655
AMCCGGATGTN
>MY900631.1 Sequence 236 from patent US 11266655
AACCGGAARTR
>MY900604.1 Sequence 209 from patent US 11266655
TAAYYNAATTA
>MY900603.1 Sequence 208 from patent US 11266655
TAATYYAATTA
>MY900602.1 Sequence 207 from patent US 11266655
TAATYYAATTA
>MY900601.1 Sequence 206 from patent US 11266655
TAATYTAATTA
>MY900598.1 Sequence 203 from patent US 11266655
TAATYNAATTA
>MY900542.1 Sequence 147 from patent US 11266655
TCAAGGTCAWN
>MY900524.1 Sequence 129 from patent US 11266655
ACCCGGAAGTN
>MY900510.1 Sequence 115 from patent US 11266655
TTTCCCCACAC
>MY900509.1 Sequence 114 from patent US 11266655
TTTAAAGGTCA
>MY900471.1 Sequence 76 from patent US 11266655
CACCGAACAAT
>MY898869.1 Sequence 1 from patent US 11261452
GAAAACAACAG
>MY887719.1 Sequence 13 from patent US 11255847
TTTTTTTTTTT
>MY887718.1 Sequence 12 from patent US 11255847
AAAAAAAAAAA
>MY887338.1 Sequence 100 from patent US 11254989
TTTAGAGCCCC
>MY887247.1 Sequence 9 from patent US 11254989
TCTATGACCTG
>MY885770.1 Sequence 23 from patent US 11254961
AAAAAAACTAG
>MY885764.1 Sequence 17 from patent US 11254961
TTTCTAGTTTT
>MY885763.1 Sequence 16 from patent US 11254961
CTAGTTTTTTT
>MY885762.1 Sequence 15 from patent US 11254961
CTAGTTTTTTT
>MY884325.1 Sequence 37 from patent US 11254928
TGCTTGGAAAG
>MY867200.1 Sequence 143 from patent US 11253589
TGCGNRGGNGK
>MY867196.1 Sequence 137 from patent US 11253589
CCTAGGTGGGA
>MY867194.1 Sequence 135 from patent US 11253589
CCCGCCTCCAC
>MY867193.1 Sequence 134 from patent US 11253589
CTCCACCTAAA
>MY867192.1 Sequence 133 from patent US 11253589
CTTCCCTCCAC
>MY867187.1 Sequence 128 from patent US 11253589
GTGGGGGCAAG
>MY867183.1 Sequence 124 from patent US 11253589
GTGGGCGGGGG
>MY867178.1 Sequence 119 from patent US 11253589
GGAAGGTGAGT
>MY867177.1 Sequence 118 from patent US 11253589
TTCCACCTGAC
>MY867176.1 Sequence 117 from patent US 11253589
GCTGCTCCCTC
>MY867175.1 Sequence 116 from patent US 11253589
TTTCACCTATG
>MY867174.1 Sequence 115 from patent US 11253589
TCCGTCCCCAC
>MY867173.1 Sequence 114 from patent US 11253589
CTGCACCTGAG
>MY867172.1 Sequence 113 from patent US 11253589
CTCACCCCCAC
>MY867168.1 Sequence 109 from patent US 11253589
GTGGCGGCGGC
>MY867167.1 Sequence 108 from patent US 11253589
GTGGTGGCGGC
>MY867163.1 Sequence 104 from patent US 11253589
TCCCACCTAAT
>MY867162.1 Sequence 103 from patent US 11253589
GTGGGGGGGGG
>MY867150.1 Sequence 91 from patent US 11253589
GACAGGTGAGT
>MY867148.1 Sequence 89 from patent US 11253589
GGGGGGGGGGC
>MY867147.1 Sequence 88 from patent US 11253589
GCGGGGGGGGG
>MY867144.1 Sequence 85 from patent US 11253589
TGCAGGTGAGG
>MY867139.1 Sequence 80 from patent US 11253589
TTTAGGTGGTT
>MY867138.1 Sequence 79 from patent US 11253589
CCCACCCCCAG
>MY867137.1 Sequence 78 from patent US 11253589
GCAGCCCCCAC
>MY867132.1 Sequence 73 from patent US 11253589
TTTAGGTGTGT
>MY867127.1 Sequence 68 from patent US 11253589
CTCTCCCCCAC
>MY867126.1 Sequence 67 from patent US 11253589
CCAAGGTGAGC
>MY867123.1 Sequence 64 from patent US 11253589
CCCCCCCCCAC
>MY867122.1 Sequence 63 from patent US 11253589
GTGGGGGGAGT
>MY867121.1 Sequence 62 from patent US 11253589
CCCAGGTGGGT
>MY867120.1 Sequence 61 from patent US 11253589
GCGGGGGGAGG
>MY867119.1 Sequence 60 from patent US 11253589
GTTGGGGCGGG
>MY867112.1 Sequence 53 from patent US 11253589
TTCCCTCCCAC
>MY867111.1 Sequence 52 from patent US 11253589
CCCGCACCCAC
>MY867106.1 Sequence 47 from patent US 11253589
ACTCACCTCAG
>MY867104.1 Sequence 45 from patent US 11253589
CCCCCCCCCAC
>MY867103.1 Sequence 44 from patent US 11253589
GCTGGCCCCAC
>MY867100.1 Sequence 41 from patent US 11253589
GTGGGAGCGAG
>MY867099.1 Sequence 40 from patent US 11253589
TGAAGGTGGGA
>MY867098.1 Sequence 39 from patent US 11253589
GCGGGGGGGGG
>MY867097.1 Sequence 38 from patent US 11253589
GCGGGCGGGGG
>MY867092.1 Sequence 33 from patent US 11253589
ATGGGGGCAAC
>MY867091.1 Sequence 32 from patent US 11253589
GTGGGCGGGAT
>MY867082.1 Sequence 23 from patent US 11253589
TACAGGTGATT
>MY867076.1 Sequence 17 from patent US 11253589
GCGGGGGCAGG
>MY867075.1 Sequence 16 from patent US 11253589
GGGGGCGCGGG
>MY867068.1 Sequence 9 from patent US 11253589
TGTGCGTGTTA
>MY867067.1 Sequence 8 from patent US 11253589
GGACACGCAGC
>MY866755.1 Sequence 8 from patent US 11253536
AGCTCTCGAGT
>MY860710.1 Sequence 73 from patent US 11248056
GACAACTCTTT
>MY844249.1 Sequence 461 from patent US 11246889
GRTVDGTVVSD
>MY843051.1 Sequence 3 from patent US 11242560
GGGGGTAAAAC
>MY843041.1 Sequence 7 from patent US 11242554
MGTTCTGGATM
>MY843040.1 Sequence 6 from patent US 11242554
MGTTCCGGAMM
>MY843038.1 Sequence 4 from patent US 11242554
MGTTCTGGATA
>MY843037.1 Sequence 3 from patent US 11242554
MGTTCCGGAMA
>MY843036.1 Sequence 2 from patent US 11242554
MGTTCTGGATM
>MY843035.1 Sequence 1 from patent US 11242554
MGTTCCGGAMM
>MY835429.1 Sequence 131 from patent US 11242533
TGATCCTGGGT
>MY835386.1 Sequence 86 from patent US 11242533
CCCAGGCTACG
>MY834768.1 Sequence 16319 from patent US 11242525
CTGTTTTGGAA
>MY834761.1 Sequence 16312 from patent US 11242525
ATAAGTAGCAC
>MY805032.1 Sequence 171 from patent US 11236364
AATTTCTACTG
>MY805031.1 Sequence 170 from patent US 11236364
AATTTCTACTG
>MY805030.1 Sequence 169 from patent US 11236364
AATTTCTACTG
>MY805029.1 Sequence 168 from patent US 11236364
AATTTCTACTG
>MY803821.1 Sequence 11 from patent US 11236336
GGTTCACTGTG
>MY800948.1 Sequence 5 from patent US 11234936
GGGATCCTACC
>MY800249.1 Sequence 10 from patent US 11230732
TACGCCACCAG
>MY800247.1 Sequence 8 from patent US 11230732
GCTGATGGCGT
>MY800245.1 Sequence 6 from patent US 11230732
CTGGTGGCGTA
>pdb|7YGC|B Chain B, Cryo-EM structure of Tetrahymena ribozyme conformation 4 undergoing the second-step self-splicing
CCCTCTNAACC
>pdb|7SPL|B Chain B, [2T3] Self-assembling 3D DNA triangle with three inter-junction base pairs containing the L1 junction and a zero-linked center strand
NAGTTCATCCT
>PA565254.1 WO 2022255411-A/12: Enhancement of innate immune response
ATACNNACCTG
>pdb|8FIX|R Chain R, Cryo-EM structure of E. coli RNA polymerase backtracked elongation complex harboring a terminal mismatch
NCGGACAATTT
>pdb|7YGB|B Chain B, Cryo-EM structure of Tetrahymena ribozyme conformation 3 undergoing the second-step self-splicing
CCCTCTNAACC
>pdb|7UFX|F Chain F, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold-insert duplexes (21mer and 10mer) containing the cognate REPE54 sequence and an additional G-C rich sequence, respectively.
AGTCCGGGCCG
>pdb|7UFX|E Chain E, Isoreticular, interpenetrating co-crystal of Replication Initiator Protein REPE54 and scaffold-insert duplexes (21mer and 10mer) containing the cognate REPE54 sequence and an additional G-C rich sequence, respectively.
AGACGGCCCGG
>pdb|7XRC|B Chain B, Crystal Structure of the dimeric Brn2 (Pou3f2) POU domain bound to palindromic MORE DNA
NCTCATGCATA
>pdb|7XRC|A Chain A, Crystal Structure of the dimeric Brn2 (Pou3f2) POU domain bound to palindromic MORE DNA
ATGCATGAGGA
>pdb|7M07|T Chain T, Pre-catalytic ternary complex of DNA Polymerase Lambda with bound 1-nt gapped SSB substrate and incoming dUMPNPP
CGGCAGTACTG
>pdb|8D4A|G Chain G, Cas12a2 quaternary complex
NAAAAAAAAAA
>pdb|8D4A|D Chain D, Cas12a2 quaternary complex
NTTTTTTTTTT
>pdb|8A1C|C Chain C, TraI trans-esterase domain from pKM101 (DNA bound)
GCGTTAGGTGT
>pdb|4V7E|Af Chain Af, Model of the small subunit RNA based on a 5.5 A cryo-EM map of Triticum aestivum translating 80S ribosome
AAAAGACTTCA
>PA561440.1 WO 2022220141-A/159: Method for detecting mutant SARS-CoV-2
CCGCCGACGAG
>PA561437.1 WO 2022220141-A/156: Method for detecting mutant SARS-CoV-2
CGCCGATGAGA
>PA561432.1 WO 2022220141-A/151: Method for detecting mutant SARS-CoV-2
CGCCGAGGAGA
>PA561323.1 WO 2022220141-A/42: Method for detecting mutant SARS-CoV-2
ATGGTGTTGAA
>PA559581.1 JP 2022154093-A/5: Method for detecting SNP
TGTCTGAAACC
>PE006636.1 KR 1020220080012-A/2744: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>PE006635.1 KR 1020220080012-A/2743: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>PE006616.1 KR 1020220080012-A/2724: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>PE002463.1 KR 1020220075451-A/461: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
GRTVDGTVVSD
>PE002128.1 KR 1020220073865-A/13: METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY
AGTCGAAAAAC
>PE002117.1 KR 1020220073865-A/2: METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY
AGCTGATATTG
>pdb|7YPQ|Q Chain Q, Cryo-EM structure of one baculovirus LEF-3 molecule in complex with ssDNA
NAAAAAAAAAA
>OF490589.1 KR 1020220070324-A/256: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
CCCACTCGCCA
>OF490538.1 KR 1020220070324-A/205: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
CCCACTCGCCA
>OF490537.1 KR 1020220070324-A/204: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
CCCACTCGCCA
>OF448812.1 KR 1020220025839-A/290: TRANSGENIC MAMMALS AND METHODS OF USE THEREOF
AAACCAACGGT
>OF405832.1 KR 1020220035338-A/65: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
ATCACAGATGA
>OF405830.1 KR 1020220035338-A/63: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
ATTTCCTGTAG
>OF405808.1 KR 1020220035338-A/41: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
ATGTCAAAATT
>OF405807.1 KR 1020220035338-A/40: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
AATTTTGACTA
>OF405792.1 KR 1020220035338-A/25: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
ATCGCCACTGC
>OF448517.1 KR 1020220025838-A/466: TRANSGENIC MAMMALS AND METHODS OF USE
AAACCAACGGT
>OF448146.1 KR 1020220025838-A/95: TRANSGENIC MAMMALS AND METHODS OF USE
CTAACTGGGGC
>OF404848.1 KR 1020220002718-A/205: NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES
CTAACTGGGGA
>OF403898.1 KR 1020220024160-A/19: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
GTCATACACGG
>OF403884.1 KR 1020220024160-A/5: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
TCATACACGGC
>OF485051.1 KR 1020220054727-A/13: MODULATORY POLYNUCLEOTIDES
CCTGACCCAGT
>OF483169.1 KR 1020220076478-A/13: A Method for Identifying, Recognizing or Targeting a DNA Base or Specific DNA Base Sequence by Utilizing a PPR Protein
AATTTGTCGAT
>OF481644.1 KR 1020220053048-A/146: Antisense nucleic acids
ACAGTTTGCCG
>OF481642.1 KR 1020220053048-A/144: Antisense nucleic acids
CCTGGAGTTCC
>OF439123.1 KR 1020220044266-A/3521: CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
ATCGGGCTAGC
>OF389387.1 KR 1020220023985-A/19: EFFICIENT PPR PROTEIN PRODUCTION METHOD AND USE THEREOF
GTGGTGAGACC
>OF389386.1 KR 1020220023985-A/18: EFFICIENT PPR PROTEIN PRODUCTION METHOD AND USE THEREOF
GGTCTCAATAC
>OF388339.1 KR 1020220009980-A/240: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
ATTATGGGAGA
>OF388338.1 KR 1020220009980-A/239: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGACTCTGCTC
>OF388337.1 KR 1020220009980-A/238: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGACGCTGCTA
>OF388336.1 KR 1020220009980-A/237: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGACGCTACTC
>OF388335.1 KR 1020220009980-A/236: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
ACACGCTGCTC
>OF388334.1 KR 1020220009980-A/235: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGACGGTGCTC
>OF388333.1 KR 1020220009980-A/234: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
TGACGCTGCTT
>OF388332.1 KR 1020220009980-A/233: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGACGCTGCTC
>OF388331.1 KR 1020220009980-A/232: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
ATAGTGAGGAC
>OF388330.1 KR 1020220009980-A/231: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
ACAGTGAGGAC
>OF388329.1 KR 1020220009980-A/230: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
AGAGTGAGGAC
>OF388328.1 KR 1020220009980-A/229: REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
CGAAGACGCTG
>OF388233.1 KR 1020220007104-A/16: CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES
AATATCTGCAA
>OF472137.1 KR 1020220079551-A/52: TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT
TACAAAAAGCA
>OF472134.1 KR 1020220079551-A/49: TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT
TACAAAAGCAG
>OF471710.1 KR 1020220051401-A/193: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
CAGTGGGTAAG
>OF471678.1 KR 1020220051401-A/161: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
CACACGACTTC
>OF387186.1 KR 1020220002609-A/714: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
CTTCCCTCCCA
>OF387182.1 KR 1020220002609-A/710: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
GTAAGGTTGAC
>OF469628.1 KR 1020220049619-A/407: SYSTEM FOR REGULATING GENE EXPRESSION
GCGTTCCTTGT
>OF469624.1 KR 1020220049619-A/403: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCTGTG
>OF469623.1 KR 1020220049619-A/402: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGATCTGGG
>OF469612.1 KR 1020220049619-A/391: SYSTEM FOR REGULATING GENE EXPRESSION
GCGTTTACTTC
>OF469505.1 KR 1020220049619-A/284: SYSTEM FOR REGULATING GENE EXPRESSION
GCTAAGTACCT
>OF469472.1 KR 1020220049619-A/251: SYSTEM FOR REGULATING GENE EXPRESSION
CTCGTGATTGG
>OF469465.1 KR 1020220049619-A/244: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTGATCACG
>OF469456.1 KR 1020220049619-A/235: SYSTEM FOR REGULATING GENE EXPRESSION
CCTAATAAAGT
>OF469437.1 KR 1020220049619-A/216: SYSTEM FOR REGULATING GENE EXPRESSION
CTCCTAATTGG
>OF469419.1 KR 1020220049619-A/198: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTCCACGAG
>OF469405.1 KR 1020220049619-A/184: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTCCACGAG
>OF469397.1 KR 1020220049619-A/176: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAAA
>OF469369.1 KR 1020220049619-A/148: SYSTEM FOR REGULATING GENE EXPRESSION
TCGTGTCGGGT
>OF469360.1 KR 1020220049619-A/139: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTGCGCAGG
>OF469358.1 KR 1020220049619-A/137: SYSTEM FOR REGULATING GENE EXPRESSION
CCTGCCGGGTG
>OF469340.1 KR 1020220049619-A/119: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAAA
>OF469333.1 KR 1020220049619-A/112: SYSTEM FOR REGULATING GENE EXPRESSION
CTTTGTGCAGG
>OF469324.1 KR 1020220049619-A/103: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAAA
>OF469322.1 KR 1020220049619-A/101: SYSTEM FOR REGULATING GENE EXPRESSION
TTTGGACAACA
>OF469319.1 KR 1020220049619-A/98: SYSTEM FOR REGULATING GENE EXPRESSION
TTTGGACAACA
>OF469318.1 KR 1020220049619-A/97: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAAA
>OF469317.1 KR 1020220049619-A/96: SYSTEM FOR REGULATING GENE EXPRESSION
TTTGGACAACA
>OF381840.1 KR 1020220012245-A/149: NOVEL OMNI-50 CRISPR NUCLEASE
CGAGTTCAAAT
>OF381743.1 KR 1020220012245-A/32: NOVEL OMNI-50 CRISPR NUCLEASE
GGGTTTATCCC
>OF381733.1 KR 1020220012245-A/22: NOVEL OMNI-50 CRISPR NUCLEASE
GGCTTTATGCC
>OF380344.1 KR 1020220002910-A/25: TRIPLE HELIX TERMINATOR FOR EFFICIENT RNA TRANS-SPLICING
AAAAAGCAAAA
>OF380338.1 KR 1020220002910-A/19: TRIPLE HELIX TERMINATOR FOR EFFICIENT RNA TRANS-SPLICING
TTTTGCTTTTT
>OF379465.1 KR 1020220002882-A/4: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
CAGGTAAGTAT
>OF379427.1 KR 1020220010471-A/27: ELECTROCHEMILUMINESCENT LABELED PROBES FOR USE IN IMMUNOASSAY METHODS, METHODS USING SUCH AND KITS COMPRISING SAME
AAGCGTCTTAA
>OF374813.1 KR 1020220031527-A/2: Method for detecting noxious substance of food
TAATCATGATT
>OF374361.1 KR 1020220040983-A/19: Prime editing-based gene editing composition with improved editing efficiency and use thereof
TCAACATGGGC
>OF374352.1 KR 1020220040983-A/10: Prime editing-based gene editing composition with improved editing efficiency and use thereof
ACGTCTTCTTA
>OF372817.1 KR 1020220047502-A/551: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTTATTTTTT
>OF372689.1 KR 1020220047502-A/401: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TGTTATTTATT
>OF372687.1 KR 1020220047502-A/399: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTATTCTGTT
>OF372621.1 KR 1020220047502-A/333: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
NNNNTGAAGGA
>OF372538.1 KR 1020220047502-A/250: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
AAAGTGGAGAA
>OF372133.1 KR 1020220091052-A/2: DNA-templated Cu nanoparticle based FRET sensor and method for detecting target nucleic acid molecule using the same
CTGATAAGCTA
>OF456484.1 KR 1020220028183-A/53: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTAATAAGCT
>OF456483.1 KR 1020220028183-A/52: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
ATCTAATAAGC
>OF456476.1 KR 1020220028183-A/45: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTAATAAGCTA
>OF456470.1 KR 1020220028183-A/39: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTGATAAGCT
>OF456469.1 KR 1020220028183-A/38: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
GTCTGATAAGC
>OF456454.1 KR 1020220028183-A/23: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTGATAAGCTA
>OF368778.1 KR 1020220071536-A/17: Method and Kits for Amplifying Target Nucleic Acid with High Specificity
TACGATGCAAG
>OF367876.1 KR 1020220047493-A/23: An engineered crRNA for CRISPR/Cas12a system
ATTTTGCGTTT
>OF367875.1 KR 1020220047493-A/22: An engineered crRNA for CRISPR/Cas12a system
TTACGTTTCAT
>OF367869.1 KR 1020220047493-A/16: An engineered crRNA for CRISPR/Cas12a system
TTTGTTTCTTT
>OF367867.1 KR 1020220047493-A/14: An engineered crRNA for CRISPR/Cas12a system
TTTATTTATTT
>OF367864.1 KR 1020220047493-A/11: An engineered crRNA for CRISPR/Cas12a system
TTTTTCCATTT
>OF451705.1 KR 1020220034182-A/30: COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES
TGTAGATGGAG
>OF365743.1 KR 1020220037140-A/3: Method of detecting nucleic acids from corona virus in biological sample using Crispr/Cas system and biosensor
TTTTTATTTTT
>OF450332.1 KR 1020220021014-A/93: PREDICTING T CELL EPITOPES USEFUL FOR VACCINATION
TTCAGGACCCA
>OF490637.1 KR 1020220070324-A/304: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
CCCACTCGCCA
>OF490635.1 KR 1020220070324-A/302: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
CCCACTCGCCA
>pdb|8E3I|E Chain E, CRYO-EM STRUCTURE OF the human MPSF IN COMPLEX WITH THE AUUAAA poly(A) signal
CATTAAACAAC
>PA555645.1 WO 2022185664-A/5: translation enhancer
GGGCCAAAAGA
>PA555497.1 JP 2022134257-A/5: translation enhancer
GGGCCAAAAGA
>pdb|7QDE|A Chain A, NMR structure of Npl3 RRM12 bound to the AUCCAGUGGAA RNA
ATCCAGTGGAA
>pdb|3J9Y|x Chain x, Cryo-EM structure of tetracycline resistance protein TetM bound to a translating E.coli ribosome
AATAATGTTCG
>pdb|2IHM|U Chain U, Polymerase mu in ternary complex with gapped 11mer DNA duplex and bound incoming nucleotide
CGGCAATACTG
>pdb|2IHM|T Chain T, Polymerase mu in ternary complex with gapped 11mer DNA duplex and bound incoming nucleotide
CGGCAATACTG
>pdb|7XPL|J Chain J, Crystal structure of a C/D-free RNA-guided RNA 2'-O-methyltransferase
CCATGAGTGTT
>pdb|7XPL|I Chain I, Crystal structure of a C/D-free RNA-guided RNA 2'-O-methyltransferase
CCATGAGTGTT
>PA554139.1 JP 2022121364-A/12: CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY
AATTTTTGGAG
>PA554138.1 JP 2022121364-A/11: CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY
AATTTGTCTAG
>pdb|8D3P|L Chain L, Type I-C Cas4-Cas1-Cas2 complex bound to half-site integration intermediate (HSI)
NGATTTTCGCT
>pdb|7QVP|A5 Chain A5, Human collided disome (di-ribosome) stalled on XBP1 mRNA
NTTTTTTTTTT
>pdb|7SVB|C Chain C, APE1 exonuclease substrate complex with 8oxoG opposite C
NCGACGGATCC
>pdb|7SUV|C Chain C, APE1 exonuclease substrate complex with 8oxoG opposite A
NCGACGGATCC
>pdb|7SOV|B Chain B, LaM domain of human LARP1 in complex with AAAAAAAAAAA RNA polynucleotide
AAAAAAAAAAA
>pdb|6YWE|ee Chain ee, The structure of the mitoribosome from Neurospora crassa in the P/E tRNA bound state
NATATTTATGT
>pdb|3JBV|X Chain X, Mechanisms of Ribosome Stalling by SecM at Multiple Elongation Steps
NTGGCCCTCAA
>pdb|6INQ|P Chain P, RNA polymerase II elongation complex stalled at SHL(-1) of the nucleosome, with foreign DNA (+1 position)
NTGTCTTGGGT
>pdb|6A5R|P Chain P, RNA polymerase II elongation complex stalled at SHL(-2) of the nucleosome
NCTCGTGCCTG
>pdb|6A5O|P Chain P, RNA polymerase II elongation complex stalled at SHL(-6) of the nucleosome
NTGGTGTGTTT
>pdb|6YWY|ee Chain ee, The structure of the mitoribosome from Neurospora crassa with bound tRNA at the P-site
NATATTTTTGT
>pdb|5AFI|x Chain x, 2.9A Structure of E. coli ribosome-EF-TU complex by cs-corrected cryo-EM
NATAATGTTCG
>pdb|3JBU|X Chain X, Mechanisms of Ribosome Stalling by SecM at Multiple Elongation Steps
NCTGGCCCTCA
>pdb|6A5U|P Chain P, RNA polymerase II elongation complex stalled at SHL(-1) of the nucleosome, with foreign DNA, tilt conformation
NGTGTCTTGGG
>pdb|6A5T|P Chain P, RNA polymerase II elongation complex stalled at SHL(-1) of the nucleosome
NGTGTCTTGGG
>pdb|6A5P|P Chain P, RNA polymerase II elongation complex stalled at SHL(-5) of the nucleosome
NGGGTGGTGGC
>pdb|6A5L|P Chain P, RNA polymerase II elongation complex stalled at SHL(-1) of the nucleosome, with foreign DNA
NGTGTCTTGGG
>PA551475.1 JP 2022101241-A/20: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CTTATCAGACT
>PA551472.1 JP 2022101241-A/17: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CAACCTACTAC
>PA551471.1 JP 2022101241-A/16: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CAGTCTGATAA
>pdb|7R07|L Chain L, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>pdb|7R07|K Chain K, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>pdb|7R07|J Chain J, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>pdb|7R07|I Chain I, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>pdb|7R07|H Chain H, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>pdb|7R07|G Chain G, Abortive infection DNA polymerase AbiK from Lactococcus lactis
CCCCCCCCCCC
>PA550950.1 WO 2022138899-A/20: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CTTATCAGACT
>PA550947.1 WO 2022138899-A/17: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CAACCTACTAC
>PA550946.1 WO 2022138899-A/16: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CAGTCTGATAA
>PA547956.1 JP 2022086783-A/4: PROMOTER FOR FILAMENTOUS FUNGI AND USE THEREOF
CCAATCAGCGT
>pdb|7UBN|R Chain R, Transcription antitermination complex: NusA-containing "engaged" Qlambda-loading complex
TGGGAGAGGTA
>pdb|7UBM|R Chain R, Transcription antitermination complex: "pre-engaged" Qlambda-loading complex
TGGGAGAGGTA
>pdb|7SXE|B Chain B, Crystal structure of ligase I with nick duplexes containing cognate G:T
GCTGATGCGTG
>pdb|7SX5|B Chain B, Crystal structure of ligase I with nick duplexes containing mismatch A:C
GCTGATGCGTA
>pdb|7SUM|B Chain B, Crystal structure of human ligase I with nick duplexes containing cognate A:T
GCTGATGCGTA
>PA547850.1 JP 2022523148-A/74: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>PA547827.1 JP 2022523148-A/51: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>PA547825.1 JP 2022523148-A/49: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTTC
>PA547819.1 JP 2022523148-A/43: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGTGG
>PA547814.1 JP 2022523148-A/38: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGTGA
>PA547813.1 JP 2022523148-A/37: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGAGG
>PA547807.1 JP 2022523148-A/31: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAACCTC
>PA547802.1 JP 2022523148-A/26: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGTGTGAGTAC
>PA547793.1 JP 2022523148-A/17: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGACCTT
>PA547789.1 JP 2022523148-A/13: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGTA
>PA547784.1 JP 2022523148-A/8: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAACATG
>PA547109.1 WO 2022102791-A/13: Novel linker and method for detecting antigen by using thereof
TGATGATGATG
>pdb|7R6T|K Chain K, Human EXOG complexed with dRP-containing DNA
CGCACGTCAGA
>pdb|7R6T|B Chain B, Human EXOG complexed with dRP-containing DNA
CGCACGTCAGA
>pdb|7R6T|A Chain A, Human EXOG complexed with dRP-containing DNA
CGCACGTCAGA
>pdb|8DR7|K Chain K, Open state of RFC:PCNA bound to a nicked dsDNA
NGGGGGGGGGG
>pdb|8DR5|K Chain K, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) with NTD
NGGGGGGGGGG
>pdb|7R3Y|C Chain C, The crystal structure of the V426L variant of Pol2CORE in complex with DNA and an incoming nucleotide
NAACCGCGTTN
>pdb|7R3Y|P Chain P, The crystal structure of the V426L variant of Pol2CORE in complex with DNA and an incoming nucleotide
NAACCGCGTTN
>pdb|7R3X|P Chain P, The crystal structure of the L439V variant of Pol2CORE in complex with DNA and an incoming nucleotide
NAACCGCGTTN
>pdb|2LZW|B Chain B, DNA duplex containing mispair-aligned O6G-heptylene-O6G interstrand cross-link
CGAAAGTTTCG
>pdb|2LZW|A Chain A, DNA duplex containing mispair-aligned O6G-heptylene-O6G interstrand cross-link
CGAAAGTTTCG
>pdb|2LZV|B Chain B, DNA duplex containing mispair-aligned O4U-heptylene-O4U interstrand cross-link
CGAAANTTTCG
>pdb|2LZV|A Chain A, DNA duplex containing mispair-aligned O4U-heptylene-O4U interstrand cross-link
CGAAANTTTCG
>PA544623.1 JP 2022519312-A/74: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>PA544600.1 JP 2022519312-A/51: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>PA544598.1 JP 2022519312-A/49: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTTC
>PA544592.1 JP 2022519312-A/43: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGTGG
>PA544587.1 JP 2022519312-A/38: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGTGA
>PA544586.1 JP 2022519312-A/37: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGAGG
>PA544580.1 JP 2022519312-A/31: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAACCTC
>PA544575.1 JP 2022519312-A/26: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGTGTGAGTAC
>PA544566.1 JP 2022519312-A/17: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGACCTT
>PA544562.1 JP 2022519312-A/13: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGTA
>PA544557.1 JP 2022519312-A/8: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAACATG
>PA544478.1 JP 2022519296-A/51: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>PA544476.1 JP 2022519296-A/49: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTTC
>PA544470.1 JP 2022519296-A/43: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGTGG
>PA544465.1 JP 2022519296-A/38: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGTGA
>PA544464.1 JP 2022519296-A/37: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGAGG
>PA544458.1 JP 2022519296-A/31: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAACCTC
>PA544453.1 JP 2022519296-A/26: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGTGTGAGTAC
>PA544444.1 JP 2022519296-A/17: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGACCTT
>PA544440.1 JP 2022519296-A/13: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGTA
>PA544435.1 JP 2022519296-A/8: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAACATG
>PA543506.1 WO 2022085756-A/19: Tokenized gene sequence generating device, gene corpus generating device and program
TAGTTAGTTCC
>PA543501.1 WO 2022085756-A/14: Tokenized gene sequence generating device, gene corpus generating device and program
CAGCATCCAAC
>PA544501.1 JP 2022519296-A/74: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>pdb|7RIY|R Chain R, RNA polymerase II elongation complex with hairpin polyamide Py-Im 1, scaffold 2 soaked with UTP
ATCGAGAGGCT
>pdb|7M4L|T Chain T, DNA Polymerase Lambda, TTPaS:At Mn2+ Product State Ternary Complex, 60 min
CGGCAGTACTG
>pdb|7M4K|T Chain T, DNA Polymerase Lambda, TTPaS:At Ca2+ Ground State Ternary Complex
CGGCAGTACTG
>pdb|7M4J|T Chain T, DNA Polymerase Lambda, dCTP:At Mn2+ Product State Ternary Complex, 960 min
CGGCAGTACTG
>pdb|7M4I|T Chain T, DNA Polymerase Lambda, dCTP:At Mn2+ Product State Ternary Complex, 420 min
CGGCAGTACTG
>pdb|7M4H|T Chain T, DNA Polymerase Lambda, dCTP:At Mn2+ Reaction State Ternary Complex, 225 min
CGGCAGTACTG
>pdb|7M4G|T Chain T, DNA Polymerase Lambda, dCTP:At Mg2+ Product State Ternary Complex, 960 min
CGGCAGTACTG
>pdb|7M4F|T Chain T, DNA Polymerase Lambda, dCTP:At Mg2+ Product State Ternary Complex, 300 min
CGGCAGTACTG
>pdb|7M4E|T Chain T, DNA Polymerase Lambda, dCTP:At Mg2+ Reaction State Ternary Complex, 120 min
CGGCAGTACTG
>pdb|7M4D|T Chain T, DNA Polymerase Lambda, dCTP:At Ca2+ Ground State Ternary Complex
CGGCAGTACTG
>pdb|7M4C|T Chain T, DNA Polymerase Lambda, TTP:At Mn2+ Product State Ternary Complex, 960 min
CGGCAGTACTG
>pdb|7M4B|T Chain T, DNA Polymerase Lambda, TTP:At Mn2+ Product State Ternary Complex, 60 min
CGGCAGTACTG
>pdb|7M4A|T Chain T, DNA Polymerase Lambda, TTP:At Mn2+ Product State Ternary Complex, 20 min
CGGCAGTACTG
>pdb|7M49|T Chain T, DNA Polymerase Lambda, TTP:At Mn2+ Reaction State Ternary Complex, 5 min
CGGCAGTACTG
>pdb|7M48|T Chain T, DNA Polymerase Lambda, TTP:At Mg2+ Product State Ternary Complex, 960 min
CGGCAGTACTG
>pdb|7M47|T Chain T, DNA Polymerase Lambda, TTP:At Mg2+ Product State Ternary Complex, 60 min
CGGCAGTACTG
>pdb|7M46|T Chain T, DNA Polymerase Lambda, TTP:At Mg2+ Product State Ternary Complex, 5 min
CGGCAGTACTG
>pdb|7M45|T Chain T, DNA Polymerase Lambda, TTP:At Mg2+ Reaction State Ternary Complex, 120 sec
CGGCAGTACTG
>pdb|7M44|T Chain T, DNA Polymerase Lambda, TTP:At Mg2+ Reaction State Ternary Complex, 90 sec
CGGCAGTACTG
>pdb|7M43|T Chain T, DNA Polymerase Lambda, TTP:At Ca2+ Ground State Ternary Complex
CGGCAGTACTG
>pdb|6XGO|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J34 immobile Holliday junction
GAGCAGACAAG
>pdb|6XGN|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J33 immobile Holliday junction
GAGCAGACTTG
>pdb|6XGM|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J25 immobile Holliday junction
GAGCAGACGAG
>pdb|6XGL|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J36 immobile Holliday junction
GAGCAGACGTG
>pdb|6XGK|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J35 immobile Holliday junction
GAGCAGACATG
>pdb|6XGJ|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J32 immobile Holliday junction
GAGCAGACTAG
>pdb|6XG0|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J31 immobile Holliday junction
GAGCAGACCAG
>pdb|6XFZ|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J29 immobile Holliday junction
GAGCAGACAAG
>pdb|6XFY|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J28 immobile Holliday junction
GAGCAGACATG
>pdb|6XFX|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J26 immobile Holliday junction
GAGCAGACTTG
>pdb|6XFW|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J24 immobile Holliday junction
GAGCAGACCAG
>pdb|6XFG|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J23 immobile Holliday junction
GAGCAGACCTG
>pdb|6XFF|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J22 immobile Holliday junction
GAGCAGACCTG
>pdb|6XFE|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J21 immobile Holliday junction
GAGCAGACCTG
>pdb|6XFD|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J20 immobile Holliday junction
GAGCAGACGTG
>pdb|6XFC|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J19 immobile Holliday junction
GAGCAGACGAG
>pdb|6XEL|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J15 immobile Holliday junction
GAGCAGACGTG
>pdb|6XEK|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J14 immobile Holliday junction
GAGCAGACGAG
>pdb|6XEJ|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J10 immobile Holliday junction
GAGCAGACCTG
>pdb|6XEI|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J9 immobile Holliday junction
GAGCAGACGTG
>pdb|6XDZ|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J8 immobile Holliday junction
GAGCAGACCAG
>pdb|6XDY|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J7 immobile Holliday junction
GAGCAGACCAG
>pdb|6XDX|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J6 immobile Holliday junction
GAGCAGACAAG
>pdb|6XDW|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J5 immobile Holliday junction
GAGCAGACCCG
>pdb|6XDV|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J3 immobile Holliday junction
GAGCAGACGTG
>pdb|6X8C|A Chain A, Self-assembly of a 3D DNA crystal lattice (4x5 junction version) containing the J1 immobile Holliday junction
GAGCAGACCTG
>pdb|7N2M|B Chain B, Crystal structure of DNA polymerase alpha catalytic core in complex with dCTP and template/primer having T-C mismatch at the post-insertion site
GCCTGGAGCGC
>OF337498.1 KR 1020210124362-A/51: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>OF337496.1 KR 1020210124362-A/49: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTTC
>OF337490.1 KR 1020210124362-A/43: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGTGG
>OF337485.1 KR 1020210124362-A/38: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGTGA
>OF337484.1 KR 1020210124362-A/37: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGAGG
>OF337478.1 KR 1020210124362-A/31: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAACCTC
>OF337473.1 KR 1020210124362-A/26: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGTGTGAGTAC
>OF337464.1 KR 1020210124362-A/17: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGACCTT
>OF337460.1 KR 1020210124362-A/13: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGTA
>OF337455.1 KR 1020210124362-A/8: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAACATG
>OF336613.1 KR 1020210111887-A/104: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
CATGTCAGAGT
>OF336610.1 KR 1020210111887-A/101: ENZYME- AND AMPLIFICATION-FREE SEQUENCING
TGAGACTGTAC
>OF336489.1 KR 1020210123344-A/51: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGGTGGGTTT
>OF336487.1 KR 1020210123344-A/49: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CTGGTGAGTTC
>OF336481.1 KR 1020210123344-A/43: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTGAGTGG
>OF336476.1 KR 1020210123344-A/38: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGTGA
>OF336475.1 KR 1020210123344-A/37: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAGGAGG
>OF336469.1 KR 1020210123344-A/31: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
CAGGTAACCTC
>OF336464.1 KR 1020210123344-A/26: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AGTGTGAGTAC
>OF336455.1 KR 1020210123344-A/17: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTGACCTT
>OF336451.1 KR 1020210123344-A/13: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAATGTA
>OF336446.1 KR 1020210123344-A/8: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
AAGGTAACATG
>OF334531.1 KR 1020210107906-A/23: USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
CTAACCCTAAC
>OF334183.1 KR 1020210151049-A/519: TREM COMPOSITIONS AND USES THEREOF
TGCTAGAGCAT
>OF330262.1 KR 1020210133215-A/25: A METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
GGCGGCGTTAT
>OF328724.1 KR 1020210095235-A/140: RNA-GUIDEDED TRANSCRIPTIONAL REGULATION
GCCCCTTCTTC
>OF327023.1 KR 1020210125990-A/145: ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES
CGGCGGCGGCG
>OF355362.1 KR 1020210138766-A/15: PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME
GGGATTTCACC
>OF355361.1 KR 1020210138766-A/14: PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME
AATTGCATGAA
>OF355115.1 KR 1020210153632-A/4: COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
CAGGTAAGTAT
>OF315034.1 KR 1020210091180-A/10617: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF315021.1 KR 1020210091180-A/10604: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF314920.1 KR 1020210091180-A/10503: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF314912.1 KR 1020210091180-A/10495: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF314904.1 KR 1020210091180-A/10487: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF314897.1 KR 1020210091180-A/10480: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF314871.1 KR 1020210091180-A/10454: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF314858.1 KR 1020210091180-A/10441: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF314821.1 KR 1020210091180-A/10404: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF314811.1 KR 1020210091180-A/10394: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF314799.1 KR 1020210091180-A/10382: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF314786.1 KR 1020210091180-A/10369: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF314774.1 KR 1020210091180-A/10357: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF314762.1 KR 1020210091180-A/10345: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF314750.1 KR 1020210091180-A/10333: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF314738.1 KR 1020210091180-A/10321: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF314725.1 KR 1020210091180-A/10308: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF314712.1 KR 1020210091180-A/10295: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF314699.1 KR 1020210091180-A/10282: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF314689.1 KR 1020210091180-A/10272: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF314677.1 KR 1020210091180-A/10260: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF314661.1 KR 1020210091180-A/10244: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF314648.1 KR 1020210091180-A/10231: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF314547.1 KR 1020210091180-A/10130: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF314539.1 KR 1020210091180-A/10122: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF314531.1 KR 1020210091180-A/10114: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF314524.1 KR 1020210091180-A/10107: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF314485.1 KR 1020210091180-A/10068: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF314498.1 KR 1020210091180-A/10081: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF314448.1 KR 1020210091180-A/10031: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF314438.1 KR 1020210091180-A/10021: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF314426.1 KR 1020210091180-A/10009: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF314413.1 KR 1020210091180-A/9996: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF314401.1 KR 1020210091180-A/9984: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF314389.1 KR 1020210091180-A/9972: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF314377.1 KR 1020210091180-A/9960: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF314365.1 KR 1020210091180-A/9948: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF314352.1 KR 1020210091180-A/9935: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF314339.1 KR 1020210091180-A/9922: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF314326.1 KR 1020210091180-A/9909: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF314316.1 KR 1020210091180-A/9899: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF314304.1 KR 1020210091180-A/9887: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF314288.1 KR 1020210091180-A/9871: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF314275.1 KR 1020210091180-A/9858: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF314174.1 KR 1020210091180-A/9757: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF314166.1 KR 1020210091180-A/9749: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF314158.1 KR 1020210091180-A/9741: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF314151.1 KR 1020210091180-A/9734: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF314125.1 KR 1020210091180-A/9708: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF314112.1 KR 1020210091180-A/9695: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF314075.1 KR 1020210091180-A/9658: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF314065.1 KR 1020210091180-A/9648: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF314053.1 KR 1020210091180-A/9636: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF314040.1 KR 1020210091180-A/9623: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF314028.1 KR 1020210091180-A/9611: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF314016.1 KR 1020210091180-A/9599: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF314004.1 KR 1020210091180-A/9587: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF313992.1 KR 1020210091180-A/9575: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF313979.1 KR 1020210091180-A/9562: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF313966.1 KR 1020210091180-A/9549: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF313953.1 KR 1020210091180-A/9536: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF313943.1 KR 1020210091180-A/9526: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF313931.1 KR 1020210091180-A/9514: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF313915.1 KR 1020210091180-A/9498: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF313902.1 KR 1020210091180-A/9485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF313801.1 KR 1020210091180-A/9384: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF313793.1 KR 1020210091180-A/9376: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF313785.1 KR 1020210091180-A/9368: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF313778.1 KR 1020210091180-A/9361: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF313752.1 KR 1020210091180-A/9335: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF313739.1 KR 1020210091180-A/9322: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF353994.1 KR 1020210131432-A/51: OPTIMIZATION OF MULTIGENE ANALYSIS OF TUMOR SAMPLES
ACAGAAAGACA
>OF313702.1 KR 1020210091180-A/9285: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF313692.1 KR 1020210091180-A/9275: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF313680.1 KR 1020210091180-A/9263: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF313667.1 KR 1020210091180-A/9250: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF313655.1 KR 1020210091180-A/9238: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF313643.1 KR 1020210091180-A/9226: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF313631.1 KR 1020210091180-A/9214: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF313619.1 KR 1020210091180-A/9202: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF313606.1 KR 1020210091180-A/9189: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF313593.1 KR 1020210091180-A/9176: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF313580.1 KR 1020210091180-A/9163: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF313570.1 KR 1020210091180-A/9153: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF313558.1 KR 1020210091180-A/9141: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF313542.1 KR 1020210091180-A/9125: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF313529.1 KR 1020210091180-A/9112: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF313428.1 KR 1020210091180-A/9011: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF313420.1 KR 1020210091180-A/9003: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF313412.1 KR 1020210091180-A/8995: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF313405.1 KR 1020210091180-A/8988: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF313379.1 KR 1020210091180-A/8962: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF313366.1 KR 1020210091180-A/8949: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF313329.1 KR 1020210091180-A/8912: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF313319.1 KR 1020210091180-A/8902: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF313307.1 KR 1020210091180-A/8890: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF313294.1 KR 1020210091180-A/8877: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF313282.1 KR 1020210091180-A/8865: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF313270.1 KR 1020210091180-A/8853: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF313258.1 KR 1020210091180-A/8841: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF313246.1 KR 1020210091180-A/8829: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF313233.1 KR 1020210091180-A/8816: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF313220.1 KR 1020210091180-A/8803: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF313207.1 KR 1020210091180-A/8790: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF313197.1 KR 1020210091180-A/8780: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF313185.1 KR 1020210091180-A/8768: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF313169.1 KR 1020210091180-A/8752: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF313055.1 KR 1020210091180-A/8638: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF313047.1 KR 1020210091180-A/8630: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF313039.1 KR 1020210091180-A/8622: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF313032.1 KR 1020210091180-A/8615: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF313006.1 KR 1020210091180-A/8589: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF312993.1 KR 1020210091180-A/8576: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF312956.1 KR 1020210091180-A/8539: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF312946.1 KR 1020210091180-A/8529: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF312934.1 KR 1020210091180-A/8517: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF312921.1 KR 1020210091180-A/8504: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF312909.1 KR 1020210091180-A/8492: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF313156.1 KR 1020210091180-A/8739: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF312897.1 KR 1020210091180-A/8480: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF312885.1 KR 1020210091180-A/8468: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF312873.1 KR 1020210091180-A/8456: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF312860.1 KR 1020210091180-A/8443: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF312847.1 KR 1020210091180-A/8430: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF312834.1 KR 1020210091180-A/8417: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF312824.1 KR 1020210091180-A/8407: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF312812.1 KR 1020210091180-A/8395: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF312796.1 KR 1020210091180-A/8379: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF312783.1 KR 1020210091180-A/8366: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF312682.1 KR 1020210091180-A/8265: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF312674.1 KR 1020210091180-A/8257: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF312665.1 KR 1020210091180-A/8248: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF312657.1 KR 1020210091180-A/8240: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF312636.1 KR 1020210091180-A/8219: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF312625.1 KR 1020210091180-A/8208: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF312612.1 KR 1020210091180-A/8195: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF312575.1 KR 1020210091180-A/8158: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF312515.1 KR 1020210091180-A/8098: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF312503.1 KR 1020210091180-A/8086: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF312527.1 KR 1020210091180-A/8110: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF312565.1 KR 1020210091180-A/8148: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF312491.1 KR 1020210091180-A/8074: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF312553.1 KR 1020210091180-A/8136: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF312478.1 KR 1020210091180-A/8061: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF312540.1 KR 1020210091180-A/8123: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF312465.1 KR 1020210091180-A/8048: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF312452.1 KR 1020210091180-A/8035: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF312442.1 KR 1020210091180-A/8025: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF312430.1 KR 1020210091180-A/8013: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF312414.1 KR 1020210091180-A/7997: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF312401.1 KR 1020210091180-A/7984: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF312300.1 KR 1020210091180-A/7883: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF312292.1 KR 1020210091180-A/7875: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF312283.1 KR 1020210091180-A/7866: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF312275.1 KR 1020210091180-A/7858: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF312254.1 KR 1020210091180-A/7837: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF312243.1 KR 1020210091180-A/7826: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF312230.1 KR 1020210091180-A/7813: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF312193.1 KR 1020210091180-A/7776: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF312183.1 KR 1020210091180-A/7766: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF312171.1 KR 1020210091180-A/7754: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF312158.1 KR 1020210091180-A/7741: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF312145.1 KR 1020210091180-A/7728: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF312133.1 KR 1020210091180-A/7716: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF312121.1 KR 1020210091180-A/7704: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF352484.1 KR 1020210130822-A/2: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME
CTAACCCTAAC
>OF312109.1 KR 1020210091180-A/7692: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF312096.1 KR 1020210091180-A/7679: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF312083.1 KR 1020210091180-A/7666: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF312070.1 KR 1020210091180-A/7653: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF312060.1 KR 1020210091180-A/7643: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF312048.1 KR 1020210091180-A/7631: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF312032.1 KR 1020210091180-A/7615: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF312019.1 KR 1020210091180-A/7602: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF311918.1 KR 1020210091180-A/7501: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF311910.1 KR 1020210091180-A/7493: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF311901.1 KR 1020210091180-A/7484: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF311893.1 KR 1020210091180-A/7476: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF311872.1 KR 1020210091180-A/7455: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF311861.1 KR 1020210091180-A/7444: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF311848.1 KR 1020210091180-A/7431: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF311811.1 KR 1020210091180-A/7394: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF311801.1 KR 1020210091180-A/7384: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF311789.1 KR 1020210091180-A/7372: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF311776.1 KR 1020210091180-A/7359: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF311763.1 KR 1020210091180-A/7346: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF311751.1 KR 1020210091180-A/7334: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF311739.1 KR 1020210091180-A/7322: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF311727.1 KR 1020210091180-A/7310: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF311714.1 KR 1020210091180-A/7297: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF311701.1 KR 1020210091180-A/7284: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF311688.1 KR 1020210091180-A/7271: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF311678.1 KR 1020210091180-A/7261: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF311666.1 KR 1020210091180-A/7249: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF311650.1 KR 1020210091180-A/7233: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF311637.1 KR 1020210091180-A/7220: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF311536.1 KR 1020210091180-A/7119: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF311528.1 KR 1020210091180-A/7111: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF311519.1 KR 1020210091180-A/7102: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF311511.1 KR 1020210091180-A/7094: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF311490.1 KR 1020210091180-A/7073: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF311479.1 KR 1020210091180-A/7062: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF311466.1 KR 1020210091180-A/7049: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF311306.1 KR 1020210091180-A/6889: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF311296.1 KR 1020210091180-A/6879: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF311284.1 KR 1020210091180-A/6867: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF311268.1 KR 1020210091180-A/6851: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF311429.1 KR 1020210091180-A/7012: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF311419.1 KR 1020210091180-A/7002: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF311255.1 KR 1020210091180-A/6838: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF311407.1 KR 1020210091180-A/6990: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF311394.1 KR 1020210091180-A/6977: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF311381.1 KR 1020210091180-A/6964: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF311369.1 KR 1020210091180-A/6952: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF311357.1 KR 1020210091180-A/6940: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF311345.1 KR 1020210091180-A/6928: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF311332.1 KR 1020210091180-A/6915: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF311319.1 KR 1020210091180-A/6902: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF311154.1 KR 1020210091180-A/6737: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF311146.1 KR 1020210091180-A/6729: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF311137.1 KR 1020210091180-A/6720: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF311129.1 KR 1020210091180-A/6712: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF311108.1 KR 1020210091180-A/6691: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF311097.1 KR 1020210091180-A/6680: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF311084.1 KR 1020210091180-A/6667: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF311047.1 KR 1020210091180-A/6630: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF311037.1 KR 1020210091180-A/6620: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF311025.1 KR 1020210091180-A/6608: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF311012.1 KR 1020210091180-A/6595: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF310999.1 KR 1020210091180-A/6582: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF310987.1 KR 1020210091180-A/6570: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF310975.1 KR 1020210091180-A/6558: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF310963.1 KR 1020210091180-A/6546: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF310950.1 KR 1020210091180-A/6533: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF310937.1 KR 1020210091180-A/6520: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF310924.1 KR 1020210091180-A/6507: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF310914.1 KR 1020210091180-A/6497: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF310902.1 KR 1020210091180-A/6485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF310886.1 KR 1020210091180-A/6469: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF310873.1 KR 1020210091180-A/6456: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF310772.1 KR 1020210091180-A/6355: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF310764.1 KR 1020210091180-A/6347: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF310755.1 KR 1020210091180-A/6338: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF310747.1 KR 1020210091180-A/6330: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF310726.1 KR 1020210091180-A/6309: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF310715.1 KR 1020210091180-A/6298: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF310702.1 KR 1020210091180-A/6285: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF310665.1 KR 1020210091180-A/6248: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF310655.1 KR 1020210091180-A/6238: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF310643.1 KR 1020210091180-A/6226: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF310630.1 KR 1020210091180-A/6213: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF310617.1 KR 1020210091180-A/6200: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF310605.1 KR 1020210091180-A/6188: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF310593.1 KR 1020210091180-A/6176: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF310581.1 KR 1020210091180-A/6164: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF310568.1 KR 1020210091180-A/6151: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF310555.1 KR 1020210091180-A/6138: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF310542.1 KR 1020210091180-A/6125: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF310532.1 KR 1020210091180-A/6115: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF310520.1 KR 1020210091180-A/6103: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF310504.1 KR 1020210091180-A/6087: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF310491.1 KR 1020210091180-A/6074: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF310390.1 KR 1020210091180-A/5973: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF310382.1 KR 1020210091180-A/5965: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF310374.1 KR 1020210091180-A/5957: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF310367.1 KR 1020210091180-A/5950: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF310339.1 KR 1020210091180-A/5922: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF310326.1 KR 1020210091180-A/5909: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF310289.1 KR 1020210091180-A/5872: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF310279.1 KR 1020210091180-A/5862: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF310267.1 KR 1020210091180-A/5850: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF310254.1 KR 1020210091180-A/5837: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF310242.1 KR 1020210091180-A/5825: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF310230.1 KR 1020210091180-A/5813: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF310218.1 KR 1020210091180-A/5801: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF310206.1 KR 1020210091180-A/5789: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF310193.1 KR 1020210091180-A/5776: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF310180.1 KR 1020210091180-A/5763: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF310167.1 KR 1020210091180-A/5750: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF310157.1 KR 1020210091180-A/5740: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF310116.1 KR 1020210091180-A/5699: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF310015.1 KR 1020210091180-A/5598: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF310007.1 KR 1020210091180-A/5590: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF309999.1 KR 1020210091180-A/5582: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF309992.1 KR 1020210091180-A/5575: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF309964.1 KR 1020210091180-A/5547: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF309951.1 KR 1020210091180-A/5534: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF310145.1 KR 1020210091180-A/5728: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF310129.1 KR 1020210091180-A/5712: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF309914.1 KR 1020210091180-A/5497: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF309904.1 KR 1020210091180-A/5487: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF309892.1 KR 1020210091180-A/5475: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF309879.1 KR 1020210091180-A/5462: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF309867.1 KR 1020210091180-A/5450: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF309855.1 KR 1020210091180-A/5438: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF309843.1 KR 1020210091180-A/5426: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF309831.1 KR 1020210091180-A/5414: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF309818.1 KR 1020210091180-A/5401: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF309805.1 KR 1020210091180-A/5388: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF309792.1 KR 1020210091180-A/5375: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF309782.1 KR 1020210091180-A/5365: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF309770.1 KR 1020210091180-A/5353: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF309754.1 KR 1020210091180-A/5337: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF309741.1 KR 1020210091180-A/5324: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF309640.1 KR 1020210091180-A/5223: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF309632.1 KR 1020210091180-A/5215: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF309624.1 KR 1020210091180-A/5207: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF309617.1 KR 1020210091180-A/5200: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF309517.1 KR 1020210091180-A/5100: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF309589.1 KR 1020210091180-A/5172: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF309504.1 KR 1020210091180-A/5087: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF309576.1 KR 1020210091180-A/5159: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF309492.1 KR 1020210091180-A/5075: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF309480.1 KR 1020210091180-A/5063: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF309468.1 KR 1020210091180-A/5051: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF309539.1 KR 1020210091180-A/5122: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF309456.1 KR 1020210091180-A/5039: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF309529.1 KR 1020210091180-A/5112: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF309443.1 KR 1020210091180-A/5026: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF309430.1 KR 1020210091180-A/5013: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF309417.1 KR 1020210091180-A/5000: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF309407.1 KR 1020210091180-A/4990: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF309395.1 KR 1020210091180-A/4978: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF309379.1 KR 1020210091180-A/4962: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF309366.1 KR 1020210091180-A/4949: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF309265.1 KR 1020210091180-A/4848: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF309257.1 KR 1020210091180-A/4840: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF309249.1 KR 1020210091180-A/4832: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF309242.1 KR 1020210091180-A/4825: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF309214.1 KR 1020210091180-A/4797: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF309201.1 KR 1020210091180-A/4784: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF309164.1 KR 1020210091180-A/4747: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF309154.1 KR 1020210091180-A/4737: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF309117.1 KR 1020210091180-A/4700: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF309105.1 KR 1020210091180-A/4688: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF309093.1 KR 1020210091180-A/4676: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF309081.1 KR 1020210091180-A/4664: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF309068.1 KR 1020210091180-A/4651: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF309055.1 KR 1020210091180-A/4638: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF309042.1 KR 1020210091180-A/4625: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF309032.1 KR 1020210091180-A/4615: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF309020.1 KR 1020210091180-A/4603: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF309004.1 KR 1020210091180-A/4587: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF308991.1 KR 1020210091180-A/4574: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF309142.1 KR 1020210091180-A/4725: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF309129.1 KR 1020210091180-A/4712: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF308890.1 KR 1020210091180-A/4473: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF308882.1 KR 1020210091180-A/4465: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF308874.1 KR 1020210091180-A/4457: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF308867.1 KR 1020210091180-A/4450: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF308839.1 KR 1020210091180-A/4422: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF308826.1 KR 1020210091180-A/4409: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF308789.1 KR 1020210091180-A/4372: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF308779.1 KR 1020210091180-A/4362: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF308767.1 KR 1020210091180-A/4350: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF308754.1 KR 1020210091180-A/4337: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF308742.1 KR 1020210091180-A/4325: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF308730.1 KR 1020210091180-A/4313: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF308718.1 KR 1020210091180-A/4301: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF308706.1 KR 1020210091180-A/4289: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF308693.1 KR 1020210091180-A/4276: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF308680.1 KR 1020210091180-A/4263: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF308667.1 KR 1020210091180-A/4250: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF308657.1 KR 1020210091180-A/4240: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF308645.1 KR 1020210091180-A/4228: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF308629.1 KR 1020210091180-A/4212: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF308616.1 KR 1020210091180-A/4199: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF308515.1 KR 1020210091180-A/4098: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF308507.1 KR 1020210091180-A/4090: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF308499.1 KR 1020210091180-A/4082: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF308492.1 KR 1020210091180-A/4075: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF308464.1 KR 1020210091180-A/4047: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF308451.1 KR 1020210091180-A/4034: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF308414.1 KR 1020210091180-A/3997: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF308404.1 KR 1020210091180-A/3987: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF308392.1 KR 1020210091180-A/3975: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF308379.1 KR 1020210091180-A/3962: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF308367.1 KR 1020210091180-A/3950: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF308355.1 KR 1020210091180-A/3938: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF308343.1 KR 1020210091180-A/3926: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF348795.1 KR 1020210122917-A/6: CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
GGGATCCTACC
>OF308331.1 KR 1020210091180-A/3914: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF308318.1 KR 1020210091180-A/3901: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF308305.1 KR 1020210091180-A/3888: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF308292.1 KR 1020210091180-A/3875: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF308282.1 KR 1020210091180-A/3865: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF308270.1 KR 1020210091180-A/3853: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF308254.1 KR 1020210091180-A/3837: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF308241.1 KR 1020210091180-A/3824: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF308140.1 KR 1020210091180-A/3723: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF307933.1 KR 1020210091180-A/3516: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF307920.1 KR 1020210091180-A/3503: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF307907.1 KR 1020210091180-A/3490: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF307897.1 KR 1020210091180-A/3480: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF307885.1 KR 1020210091180-A/3468: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF307869.1 KR 1020210091180-A/3452: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF307856.1 KR 1020210091180-A/3439: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF308132.1 KR 1020210091180-A/3715: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF308123.1 KR 1020210091180-A/3706: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF308115.1 KR 1020210091180-A/3698: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF308093.1 KR 1020210091180-A/3676: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF308080.1 KR 1020210091180-A/3663: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF308067.1 KR 1020210091180-A/3650: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF307755.1 KR 1020210091180-A/3338: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF307747.1 KR 1020210091180-A/3330: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF308030.1 KR 1020210091180-A/3613: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF308020.1 KR 1020210091180-A/3603: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF308008.1 KR 1020210091180-A/3591: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF307995.1 KR 1020210091180-A/3578: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF307982.1 KR 1020210091180-A/3565: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF307970.1 KR 1020210091180-A/3553: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF307958.1 KR 1020210091180-A/3541: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF307946.1 KR 1020210091180-A/3529: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF307738.1 KR 1020210091180-A/3321: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF307730.1 KR 1020210091180-A/3313: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF307708.1 KR 1020210091180-A/3291: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF307695.1 KR 1020210091180-A/3278: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF307682.1 KR 1020210091180-A/3265: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF307645.1 KR 1020210091180-A/3228: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF307635.1 KR 1020210091180-A/3218: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF307623.1 KR 1020210091180-A/3206: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF307610.1 KR 1020210091180-A/3193: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF307597.1 KR 1020210091180-A/3180: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF307585.1 KR 1020210091180-A/3168: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF307573.1 KR 1020210091180-A/3156: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF307561.1 KR 1020210091180-A/3144: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF307548.1 KR 1020210091180-A/3131: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF307535.1 KR 1020210091180-A/3118: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF307522.1 KR 1020210091180-A/3105: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF307512.1 KR 1020210091180-A/3095: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF307500.1 KR 1020210091180-A/3083: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF307484.1 KR 1020210091180-A/3067: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF307471.1 KR 1020210091180-A/3054: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF307323.1 KR 1020210091180-A/2906: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF307310.1 KR 1020210091180-A/2893: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF307297.1 KR 1020210091180-A/2880: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF307370.1 KR 1020210091180-A/2953: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF307260.1 KR 1020210091180-A/2843: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF307362.1 KR 1020210091180-A/2945: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF307250.1 KR 1020210091180-A/2833: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF307353.1 KR 1020210091180-A/2936: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF307345.1 KR 1020210091180-A/2928: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF307238.1 KR 1020210091180-A/2821: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF307225.1 KR 1020210091180-A/2808: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF307212.1 KR 1020210091180-A/2795: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF307200.1 KR 1020210091180-A/2783: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF307188.1 KR 1020210091180-A/2771: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF307176.1 KR 1020210091180-A/2759: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF307163.1 KR 1020210091180-A/2746: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF307150.1 KR 1020210091180-A/2733: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF307137.1 KR 1020210091180-A/2720: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF307127.1 KR 1020210091180-A/2710: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF307115.1 KR 1020210091180-A/2698: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF307099.1 KR 1020210091180-A/2682: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF307086.1 KR 1020210091180-A/2669: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF306985.1 KR 1020210091180-A/2568: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF306977.1 KR 1020210091180-A/2560: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF306968.1 KR 1020210091180-A/2551: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF306960.1 KR 1020210091180-A/2543: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF306938.1 KR 1020210091180-A/2521: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF306925.1 KR 1020210091180-A/2508: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF306912.1 KR 1020210091180-A/2495: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF306875.1 KR 1020210091180-A/2458: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF306865.1 KR 1020210091180-A/2448: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF306853.1 KR 1020210091180-A/2436: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF306742.1 KR 1020210091180-A/2325: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF306840.1 KR 1020210091180-A/2423: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF306730.1 KR 1020210091180-A/2313: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF306827.1 KR 1020210091180-A/2410: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF306714.1 KR 1020210091180-A/2297: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF306815.1 KR 1020210091180-A/2398: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF306701.1 KR 1020210091180-A/2284: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF306803.1 KR 1020210091180-A/2386: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF306791.1 KR 1020210091180-A/2374: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF306778.1 KR 1020210091180-A/2361: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF306765.1 KR 1020210091180-A/2348: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF306752.1 KR 1020210091180-A/2335: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF306540.1 KR 1020210091180-A/2123: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF306527.1 KR 1020210091180-A/2110: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF306490.1 KR 1020210091180-A/2073: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF306480.1 KR 1020210091180-A/2063: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF306468.1 KR 1020210091180-A/2051: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF306455.1 KR 1020210091180-A/2038: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF306442.1 KR 1020210091180-A/2025: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF306430.1 KR 1020210091180-A/2013: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF306418.1 KR 1020210091180-A/2001: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF306406.1 KR 1020210091180-A/1989: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF306393.1 KR 1020210091180-A/1976: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF306600.1 KR 1020210091180-A/2183: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF306592.1 KR 1020210091180-A/2175: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF306380.1 KR 1020210091180-A/1963: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF306583.1 KR 1020210091180-A/2166: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF306367.1 KR 1020210091180-A/1950: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF306575.1 KR 1020210091180-A/2158: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF306357.1 KR 1020210091180-A/1940: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF306553.1 KR 1020210091180-A/2136: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF306345.1 KR 1020210091180-A/1928: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF306329.1 KR 1020210091180-A/1912: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF306316.1 KR 1020210091180-A/1899: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF306215.1 KR 1020210091180-A/1798: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF306207.1 KR 1020210091180-A/1790: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF306198.1 KR 1020210091180-A/1781: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF306190.1 KR 1020210091180-A/1773: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF306168.1 KR 1020210091180-A/1751: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF306155.1 KR 1020210091180-A/1738: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF306142.1 KR 1020210091180-A/1725: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF306105.1 KR 1020210091180-A/1688: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF306095.1 KR 1020210091180-A/1678: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF306083.1 KR 1020210091180-A/1666: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF306070.1 KR 1020210091180-A/1653: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF306057.1 KR 1020210091180-A/1640: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF306045.1 KR 1020210091180-A/1628: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF306033.1 KR 1020210091180-A/1616: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF306021.1 KR 1020210091180-A/1604: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF306008.1 KR 1020210091180-A/1591: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF305995.1 KR 1020210091180-A/1578: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF305982.1 KR 1020210091180-A/1565: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF305972.1 KR 1020210091180-A/1555: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF305960.1 KR 1020210091180-A/1543: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF305944.1 KR 1020210091180-A/1527: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF305931.1 KR 1020210091180-A/1514: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF305830.1 KR 1020210091180-A/1413: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF305822.1 KR 1020210091180-A/1405: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF305814.1 KR 1020210091180-A/1397: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF305807.1 KR 1020210091180-A/1390: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF305781.1 KR 1020210091180-A/1364: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF305768.1 KR 1020210091180-A/1351: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF305731.1 KR 1020210091180-A/1314: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF305721.1 KR 1020210091180-A/1304: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF305709.1 KR 1020210091180-A/1292: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF305696.1 KR 1020210091180-A/1279: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF305684.1 KR 1020210091180-A/1267: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF305672.1 KR 1020210091180-A/1255: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF305660.1 KR 1020210091180-A/1243: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF305648.1 KR 1020210091180-A/1231: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF305635.1 KR 1020210091180-A/1218: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF305457.1 KR 1020210091180-A/1040: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF305449.1 KR 1020210091180-A/1032: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF305440.1 KR 1020210091180-A/1023: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF305432.1 KR 1020210091180-A/1015: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF305411.1 KR 1020210091180-A/994: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF305622.1 KR 1020210091180-A/1205: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF305400.1 KR 1020210091180-A/983: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF305609.1 KR 1020210091180-A/1192: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF305387.1 KR 1020210091180-A/970: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF305599.1 KR 1020210091180-A/1182: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF305587.1 KR 1020210091180-A/1170: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF305571.1 KR 1020210091180-A/1154: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF305558.1 KR 1020210091180-A/1141: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF305350.1 KR 1020210091180-A/933: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF305340.1 KR 1020210091180-A/923: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF305328.1 KR 1020210091180-A/911: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF305315.1 KR 1020210091180-A/898: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF305302.1 KR 1020210091180-A/885: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF305290.1 KR 1020210091180-A/873: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF305278.1 KR 1020210091180-A/861: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF305266.1 KR 1020210091180-A/849: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF305253.1 KR 1020210091180-A/836: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF305240.1 KR 1020210091180-A/823: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF305227.1 KR 1020210091180-A/810: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF305217.1 KR 1020210091180-A/800: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF305205.1 KR 1020210091180-A/788: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF305189.1 KR 1020210091180-A/772: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF305176.1 KR 1020210091180-A/759: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF305075.1 KR 1020210091180-A/658: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF305067.1 KR 1020210091180-A/650: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF305059.1 KR 1020210091180-A/642: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF305052.1 KR 1020210091180-A/635: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF305024.1 KR 1020210091180-A/607: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF305011.1 KR 1020210091180-A/594: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF304952.1 KR 1020210091180-A/535: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF304974.1 KR 1020210091180-A/557: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF304939.1 KR 1020210091180-A/522: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF304964.1 KR 1020210091180-A/547: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF304927.1 KR 1020210091180-A/510: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF304915.1 KR 1020210091180-A/498: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF304903.1 KR 1020210091180-A/486: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF304891.1 KR 1020210091180-A/474: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF304878.1 KR 1020210091180-A/461: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF304865.1 KR 1020210091180-A/448: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF304852.1 KR 1020210091180-A/435: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF304842.1 KR 1020210091180-A/425: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF304830.1 KR 1020210091180-A/413: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF304814.1 KR 1020210091180-A/397: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGA
>OF304801.1 KR 1020210091180-A/384: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAG
>OF304700.1 KR 1020210091180-A/283: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTT
>OF304692.1 KR 1020210091180-A/275: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATT
>OF304683.1 KR 1020210091180-A/266: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCAT
>OF304675.1 KR 1020210091180-A/258: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCA
>OF304653.1 KR 1020210091180-A/236: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGG
>OF304640.1 KR 1020210091180-A/223: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATG
>OF304627.1 KR 1020210091180-A/210: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGAT
>OF304590.1 KR 1020210091180-A/173: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGT
>OF304580.1 KR 1020210091180-A/163: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTT
>OF304568.1 KR 1020210091180-A/151: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTC
>OF304555.1 KR 1020210091180-A/138: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCT
>OF304542.1 KR 1020210091180-A/125: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTG
>OF304530.1 KR 1020210091180-A/113: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGT
>OF304518.1 KR 1020210091180-A/101: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTC
>OF304506.1 KR 1020210091180-A/89: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF304493.1 KR 1020210091180-A/76: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCA
>OF304480.1 KR 1020210091180-A/63: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAA
>OF304467.1 KR 1020210091180-A/50: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCC
>OF304457.1 KR 1020210091180-A/40: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGC
>OF304445.1 KR 1020210091180-A/28: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAG
>OF304427.1 KR 1020210091180-A/5: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCC
>OF304425.1 KR 1020210091180-A/3: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGACAGAACTT
>OF299742.1 KR 1020210131243-A/19: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CCGTGTATGAC
>OF299729.1 KR 1020210131243-A/6: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
GCCGTGTATGA
>OF299698.1 KR 1020210131242-A/19: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
CCGTGTATGAC
>OF299685.1 KR 1020210131242-A/6: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
GCCGTGTATGA
>pdb|7RBO|P Chain P, Human DNA polymerase beta crosslinked complex, 60 min Ca to Mg exchange
GCTGATGCGCC
>pdb|7RBI|P Chain P, Human DNA polymerase beta crosslinked complex, 20 s Ca to Mg exchange
GCTGATGCGCC
>pdb|6GZ4|Bx Chain Bx, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis, Translocation-intermediate-POST-2 (TI-POST-2)
NTCGTTAAAGA
>pdb|6VA3|A Chain A, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MQC
CCGGCAGTGTG
>pdb|5VS3|P Chain P, Human DNA polymerase beta 8-oxoG:dA extension with dTTP after 90 s
CTGATGCGCAT
>pdb|5VRZ|P Chain P, Human DNA polymerase beta 8-oxoG:dC extension with dTTP after 60 s
CTGATGCGCCT
>pdb|5VRY|P Chain P, Human DNA polymerase beta 8-oxoG:dC extension with dTTP after 20 s
CTGATGCGCCT
>pdb|2KY1|B Chain B, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'UAGA/3'AGAU
GACTAGAGTCA
>pdb|2KY1|A Chain A, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'UAGA/3'AGAU
GACTAGAGTCA
>pdb|2KY0|B Chain B, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'GAGC/3'CGAG
GACGAGCGTCA
>pdb|2KY0|A Chain A, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'GAGC/3'CGAG
GACGAGCGTCA
>pdb|214D|B Chain B, THE SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING A SINGLE 2'-O-METHYL-BETA-D-ARAT
GGCTANATGCG
>pdb|214D|A Chain A, THE SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING A SINGLE 2'-O-METHYL-BETA-D-ARAT
CGCATATAGCC
>pdb|2GE2|B Chain B, Solution structure of the Duplex DNA Containing the 3-(Deoxyguanosin-N2-yl)-2-Acetoaminofluorene
GCATGCGTACG
>pdb|2GE2|A Chain A, Solution structure of the Duplex DNA Containing the 3-(Deoxyguanosin-N2-yl)-2-Acetoaminofluorene
CGTACGCATGC
>pdb|7RBN|P Chain P, Human DNA polymerase beta crosslinked complex, 20 min Ca to Mg exchange
GCTGATGCGCC
>pdb|7RBM|P Chain P, Human DNA polymerase beta crosslinked complex, 60 s Ca to Mn exchange
GCTGATGCGCC
>pdb|7RBL|P Chain P, Human DNA polymerase beta crosslinked complex, 60 s Ca to Mg exchange
GCTGATGCGCC
>pdb|7N3P|D Chain D, Cryo-EM structure of the Cas12k-sgRNA-dsDNA complex
CGTAGGAGGTT
>pdb|6GZ5|Bx Chain Bx, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis, Translocation-intermediate-POST-3 (TI-POST-3)
NTCGTTAAAGA
>pdb|6VA4|A Chain A, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MIP
CCGGCAGTGTG
>pdb|5VS0|P Chain P, Human DNA polymerase beta 8-oxoG:dC extension with dTTP after 80 s
CTGATGCGCCT
>pdb|2KTP|B Chain B, Structure of the 1,N2-ethenodeoxyguanosine lesion opposite a one-base deletion in duplex DNA
GGATTCATGCG
>pdb|2KDA|B Chain B, Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein
GCATGCGTACG
>pdb|2KDA|A Chain A, Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein
CGTACNCATGC
>pdb|2KD9|B Chain B, Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein
GCATGCGTACG
>pdb|2KD9|A Chain A, Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein
CGTACNCATGC
>pdb|2K1Y|B Chain B, Solution Structure of Duplex DNA Containing the Mutagenic Lesion: 1,N2-Etheno-2'-deoxyguanine
GCATGCGTACG
>pdb|2K1Y|A Chain A, Solution Structure of Duplex DNA Containing the Mutagenic Lesion: 1,N2-Etheno-2'-deoxyguanine
CGTACNCATGC
>pdb|2GKD|C Chain C, Structural insight into self-sacrifice mechanism of enediyne resistance
CTATCATATGC
>pdb|2GKD|B Chain B, Structural insight into self-sacrifice mechanism of enediyne resistance
GCATATGATAG
>pdb|7RBK|P Chain P, Human DNA polymerase beta crosslinked complex, 40 s Ca to Mg exchange
GCTGATGCGCC
>pdb|7RBJ|P Chain P, Human DNA polymerase beta crosslinked complex, 30 s Ca to Mg exchange
GCTGATGCGCC
>pdb|5VS4|P Chain P, Human DNA polymerase beta 8-oxoG:dA extension with dTTP after 120 s
CTGATGCGCAT
>pdb|2KXZ|B Chain B, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'AAGU/3'UGAA
GACAAGTGTCA
>pdb|2KXZ|A Chain A, The Structure of RNA Internal Loops with Tandem AG Pairs: 5'AAGU/3'UGAA
GACAAGTGTCA
>MY792781.1 Sequence 11 from patent US 11211146
TTGGATATGGG
>MY787240.1 Sequence 4 from patent US 11208692
GTAGTAGTACG
>MY776031.1 Sequence 1471 from patent US 11208638
TGGGCTGTCAA
>MY768369.1 Sequence 1374 from patent US 11203783
ACGACGGGAGT
>MY768368.1 Sequence 1373 from patent US 11203783
ACTCGTAGAGT
>MY768367.1 Sequence 1372 from patent US 11203783
AGAGACGGAGT
>MY768366.1 Sequence 1371 from patent US 11203783
ACGATCTGCGT
>MY768365.1 Sequence 1370 from patent US 11203783
ACACAGTGCGT
>MY768364.1 Sequence 1369 from patent US 11203783
AGTGTGTGCGT
>MY768363.1 Sequence 1368 from patent US 11203783
ACTAGAGGCGT
>MY768362.1 Sequence 1367 from patent US 11203783
AGTCTACGCGT
>MY768361.1 Sequence 1366 from patent US 11203783
ATACGTGGCGT
>MY768360.1 Sequence 1365 from patent US 11203783
ACGAGTGGTGT
>MY768359.1 Sequence 1364 from patent US 11203783
ATACTAGGTGT
>MY768358.1 Sequence 1363 from patent US 11203783
AGTCGTGGTGT
>MY768357.1 Sequence 1362 from patent US 11203783
ACTCGCGTCGT
>MY768356.1 Sequence 1361 from patent US 11203783
ACTATACGAGT
>MY768355.1 Sequence 1360 from patent US 11203783
ACTACGTCTCT
>MY768354.1 Sequence 1359 from patent US 11203783
ACGTAGATCGT
>MY768353.1 Sequence 1358 from patent US 11203783
ACGTACTGTGT
>MY768352.1 Sequence 1357 from patent US 11203783
ACGTACACACT
>MY768351.1 Sequence 1356 from patent US 11203783
ACGCGTCTAGT
>MY768350.1 Sequence 1355 from patent US 11203783
ACGAGTAGACT
>MY768349.1 Sequence 1354 from patent US 11203783
ACGACACGTAT
>MY768348.1 Sequence 1353 from patent US 11203783
ACACTACTCGT
>MY768347.1 Sequence 1352 from patent US 11203783
ACACGTAGTAT
>MY768346.1 Sequence 1351 from patent US 11203783
ACACGACGACT
>MY768091.1 Sequence 30 from patent US 11203780
CTCGCAGGAAC
>MY764557.1 Sequence 297 from patent US 11203611
TCCATGTCGTT
>MY764477.1 Sequence 217 from patent US 11203611
TCGTTGTCGTT
>MY764455.1 Sequence 191 from patent US 11203611
TCGTCGTCGTT
>MY754825.1 Sequence 62 from patent US 11198875
CCAGCTATGTG
>MY751872.1 Sequence 8 from patent US 11198873
CCTGACCCAGT
>MY743038.1 Sequence 13 from patent US 11193129
CCTGACCCAGT
>MY742223.1 Sequence 116 from patent US 11193125
CGCCGCCATTT
>MY742222.1 Sequence 115 from patent US 11193125
TCTGTTAGCCA
>MY741756.1 Sequence 2826 from patent US 11192982
GGTACGTCTTC
>MY736309.1 Sequence 123 from patent US 11186850
AAAAATTGTTG
>MY734724.1 Sequence 15 from patent US 11186839
AGCTCTCGAGT
>MY732380.1 Sequence 4 from patent US 11186822
TGCCTACTGCC
>MY732378.1 Sequence 2 from patent US 11186822
GACAGTGAGCG
>MY727603.1 Sequence 3 from patent US 11180805
TTTTTTTTTTT
>MY727602.1 Sequence 2 from patent US 11180805
AAAAAAAAAAA
>MY722107.1 Sequence 1471 from patent US 11180792
TGGGCTGTCAA
>MY713977.1 Sequence 232 from patent US 11180743
TTTTTTTTTTT
>MY705809.1 Sequence 1 from patent US 11177020
CATAATACTAG
>MY680425.1 Sequence 9 from patent US 11168373
TNNNTNNNCTG
>MY680356.1 Sequence 46 from patent US 11168369
CTAACCTCCTA
>MY680355.1 Sequence 45 from patent US 11168369
TAGGAGGTTAG
>MY680325.1 Sequence 3 from patent US 11168367
ACNNNNNCTCC
>MY680323.1 Sequence 1 from patent US 11168367
ACNNNNGTAYC
>MY680013.1 Sequence 10 from patent US 11168350
CTCGGCCCGAT
>MY678970.1 Sequence 7 from patent US 11168325
TAAGCACTTTG
>MY678893.1 Sequence 167 from patent US 11168322
CTAAAACNNNN
>MY678892.1 Sequence 166 from patent US 11168322
CTAAAACNNNN
>MY678891.1 Sequence 165 from patent US 11168322
CTAAAACNNNN
>MY678890.1 Sequence 164 from patent US 11168322
CTAAAACNNNN
>MY677782.1 Sequence 73 from patent US 11168141
GACAACTCTTT
>MY676445.1 Sequence 145 from patent US 11166996
CGGCGGCGGCG
>MY676378.1 Sequence 198 from patent US 11166994
GCTAGCTCTGG
>MY676377.1 Sequence 197 from patent US 11166994
CGATCGAGACC
>MY676184.1 Sequence 4 from patent US 11166994
ATGGCGATCGC
>MY672631.1 Sequence 34 from patent US 11162960
GGGAGACAAGG
>MY672099.1 Sequence 11 from patent US 11162142
GGCAAGGGGAG
>MY671259.1 Sequence 566 from patent US 11162114
CCTGGCTCTCC
>MY668119.1 Sequence 714 from patent US 11162102
CTTCCCTCCCA
>MY668115.1 Sequence 710 from patent US 11162102
GTAAGGTTGAC
>MY667401.1 Sequence 116 from patent US 11162101
GGAGTAAGTCT
>MY667400.1 Sequence 115 from patent US 11162101
ATACTTACCTG
>MY667359.1 Sequence 74 from patent US 11162101
GAGGTGGGTTT
>MY667336.1 Sequence 51 from patent US 11162101
GAGGTGGGTTT
>MY667334.1 Sequence 49 from patent US 11162101
CTGGTGAGTTC
>MY667328.1 Sequence 43 from patent US 11162101
CAGGTGAGTGG
>MY667323.1 Sequence 38 from patent US 11162101
CAGGTAGGTGA
>MY667322.1 Sequence 37 from patent US 11162101
CAGGTAGGAGG
>MY667316.1 Sequence 31 from patent US 11162101
CAGGTAACCTC
>MY667311.1 Sequence 26 from patent US 11162101
AGTGTGAGTAC
>MY667302.1 Sequence 17 from patent US 11162101
AAGGTGACCTT
>MY667298.1 Sequence 13 from patent US 11162101
AAGGTAATGTA
>MY667293.1 Sequence 8 from patent US 11162101
AAGGTAACATG
>MY661819.1 Sequence 117 from patent US 11160260
AGCCAGCGTGC
>MY661584.1 Sequence 93 from patent US 11156617
TTCAGGACCCA
>MY661391.1 Sequence 43 from patent US 11156599
TAGGGTTAGGG
>MY661105.1 Sequence 56 from patent US 11155882
CTCGTTCGTTC
>MY661104.1 Sequence 55 from patent US 11155882
CTCGTTCGTTC
>MY661103.1 Sequence 54 from patent US 11155882
CTCGTTCGTTC
>MY661102.1 Sequence 53 from patent US 11155882
CTCGTTCGTTC
>MY661101.1 Sequence 52 from patent US 11155882
CTCGTTCGTTC
>MY661100.1 Sequence 51 from patent US 11155882
CTCGTTCGTTC
>MY661098.1 Sequence 49 from patent US 11155882
CTCGTTCGTTC
>MY661097.1 Sequence 48 from patent US 11155882
CTCGTTCGTTC
>MY661091.1 Sequence 42 from patent US 11155882
CTCGATCGTTC
>MY661090.1 Sequence 41 from patent US 11155882
CTCGTTCGTTC
>MY661089.1 Sequence 40 from patent US 11155882
CTCGAACGTTC
>MY661085.1 Sequence 36 from patent US 11155882
CTCGTACGTTC
>MY661080.1 Sequence 24 from patent US 11155882
TTTTTTTTTTT
>MY661079.1 Sequence 19 from patent US 11155882
TATTATTTTTT
>MY661078.1 Sequence 18 from patent US 11155882
TGTTGTTTTTT
>MY661077.1 Sequence 17 from patent US 11155882
TTTTTTTTTTT
>MY661076.1 Sequence 16 from patent US 11155882
TTTTTTTTTTT
>MY661075.1 Sequence 15 from patent US 11155882
CCCCTTCCCCC
>MY661074.1 Sequence 14 from patent US 11155882
TTTTTTTTTTT
>MY661073.1 Sequence 11 from patent US 11155882
TTTTTTTTTTT
>MY661072.1 Sequence 10 from patent US 11155882
TTTTTTTTTTT
>MY661071.1 Sequence 9 from patent US 11155882
TTTTTTTTTTT
>MY661070.1 Sequence 8 from patent US 11155882
TTTTTTTTTTT
>MY661069.1 Sequence 7 from patent US 11155882
TTTTTTTTTTT
>MY661067.1 Sequence 5 from patent US 11155882
TTTTTTTTTTT
>MY660577.1 Sequence 1 from patent US 11155865
CGATCGATCGA
>MY660406.1 Sequence 6 from patent US 11155858
CGTCTCCTCAG
>MY660404.1 Sequence 2 from patent US 11155858
ACCACGGTCAC
>MY653945.1 Sequence 361 from patent US 11149320
AACACCCTGAT
>MY653944.1 Sequence 360 from patent US 11149320
AACATCCTGAT
>MY653836.1 Sequence 252 from patent US 11149320
TCAGGGTGTTA
>MY653835.1 Sequence 251 from patent US 11149320
TCAGGATGTTA
>MY651275.1 Sequence 23 from patent US 11149302
GCGTATAATGG
>MY615551.1 Sequence 60 from patent US 11149092
CTTGCGTGAGC
>MY613823.1 Sequence 39 from patent US 11147830
GTTTTTGTACT
>MY613816.1 Sequence 25 from patent US 11147830
AATCATTTGAG
>MY613815.1 Sequence 24 from patent US 11147830
TTTCATTTGAG
>MY608557.1 Sequence 29 from patent US 11142775
ACCGTGTCCCG
>MY606869.1 Sequence 20 from patent US 11142764
AGNAACNCCAC
>MY606868.1 Sequence 19 from patent US 11142764
NCANCNNNGCN
>MY606867.1 Sequence 18 from patent US 11142764
GGCNGCNGGCA
>MY606866.1 Sequence 17 from patent US 11142764
NNGCGCNCGNN
>MY606865.1 Sequence 16 from patent US 11142764
CCANGCAGCAC
>MY606864.1 Sequence 15 from patent US 11142764
GCCNGNNANCC
>MY606863.1 Sequence 14 from patent US 11142764
AGNGCNCNACC
>MY606862.1 Sequence 13 from patent US 11142764
NNNGANCANCG
>MY606861.1 Sequence 12 from patent US 11142764
NNCCNGCCANA
>MY606860.1 Sequence 11 from patent US 11142764
CGCNCANCNAA
>MY606859.1 Sequence 10 from patent US 11142764
GNNCAAACANA
>MY606858.1 Sequence 9 from patent US 11142764
AGNNNCNCNCC
>MY606857.1 Sequence 8 from patent US 11142764
NGGNNCNGCAN
>MY606856.1 Sequence 7 from patent US 11142764
GACANGNCNAN
>MY606855.1 Sequence 6 from patent US 11142764
GNCNANNCNCC
>MY606854.1 Sequence 5 from patent US 11142764
GCANNNGACCN
>MY606853.1 Sequence 4 from patent US 11142764
NNNANCCANNG
>MY606852.1 Sequence 3 from patent US 11142764
CGNNNCANNAA
>MY606851.1 Sequence 2 from patent US 11142764
NGCNCANACNC
>MY606850.1 Sequence 1 from patent US 11142764
CNCANACCNNG
>MY565440.1 Sequence 8 from patent US 11136631
ACGGGCACACA
>MY565094.1 Sequence 143 from patent US 11136622
GACTTGATACC
>MY564953.1 Sequence 6 from patent US 11136621
CTAATCGGATC
>MY564952.1 Sequence 5 from patent US 11136621
GTCAGTCAATG
>MY564951.1 Sequence 4 from patent US 11136621
ACGTAGGGTCA
>MY564950.1 Sequence 3 from patent US 11136621
TAGCCTAGTAA
>MY564949.1 Sequence 2 from patent US 11136621
ACTGTCAGTAG
>MY564936.1 Sequence 51 from patent US 11136619
ACAGAAAGACA
>MY564378.1 Sequence 25 from patent US 11136595
GTGACCCCTTG
>MY560856.1 Sequence 364134 from patent US 11136386
TCCTAGGGATA
>MY560846.1 Sequence 364124 from patent US 11136386
TCCTAGCGATA
>MY558293.1 Sequence 13 from patent US 11131664
TTTTTTTTTTT
>MY558292.1 Sequence 12 from patent US 11131664
AAAAAAAAAAA
>MY557681.1 Sequence 25 from patent US 11130992
GGTGCGTGTTT
>MY557679.1 Sequence 23 from patent US 11130992
GGNGCGTGTTT
>MY557627.1 Sequence 11 from patent US 11130988
CTACTACCTCA
>MY557625.1 Sequence 9 from patent US 11130988
AACTATACAAC
>MY545760.1 Sequence 17 from patent US 11129829
GAGGTTAGAAT
>MY545759.1 Sequence 16 from patent US 11129829
AAGGTCTGTGT
>MY545754.1 Sequence 11 from patent US 11129829
CAGGTAAGTAT
>MY545753.1 Sequence 10 from patent US 11129829
ATACNNACCTG
>PA369146.1 WO 2021261592-A/6: Repeat binder
CGTGCTGCTCG
>PA369145.1 WO 2021261592-A/5: Repeat binder
CGAGCAGCACG
>pdb|7M08|T Chain T, Post-catalytic nicked complex of DNA Polymerase Lambda with bound 1-nt gapped SSB substrate and incoming dUMPNPP
CGGCAGTACTG
>pdb|1YUJ|C Chain C, SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DNA COMPLEX, 50 STRUCTURES
GTACTCTCGGC
>pdb|1YUJ|B Chain B, SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DNA COMPLEX, 50 STRUCTURES
GCCGAGAGTAC
>pdb|1YUI|C Chain C, SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DNA COMPLEX, REGULARIZED MEAN STRUCTURE
GTACTCTCGGC
>pdb|1YUI|B Chain B, SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DNA COMPLEX, REGULARIZED MEAN STRUCTURE
GCCGAGAGTAC
>pdb|1QBY|A Chain A, THE SOLUTION STRUCTURE OF A BAY-REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CGGACAAGAAG
>pdb|1X26|B Chain B, Solution structure of the AA-mismatch DNA complexed with naphthyridine-azaquinolone
CATTCAGTTAG
>pdb|1X26|A Chain A, Solution structure of the AA-mismatch DNA complexed with naphthyridine-azaquinolone
CTAACAGAATG
>pdb|1Y9H|B Chain B, Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement
GGTAGCGATGG
>pdb|1Y9H|A Chain A, Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement
CCATNGCTACC
>pdb|1TUT|B Chain B, J4/5 Loop from the Candida albicans and Candida dubliniensis Group I Introns
TCGTTAATCTC
>pdb|1TUT|A Chain A, J4/5 Loop from the Candida albicans and Candida dubliniensis Group I Introns
GAGGAAGGCGA
>pdb|1XCZ|B Chain B, Structure of DNA containing the beta-anomer of a carbocyclic abasic site
GCATGAGTACG
>pdb|1XCZ|A Chain A, Structure of DNA containing the beta-anomer of a carbocyclic abasic site
CGTACNCATGC
>pdb|1XCY|B Chain B, Structure of DNA containing the alpha-anomer of a carbocyclic abasic site
GCATGAGTACG
>pdb|1XCY|A Chain A, Structure of DNA containing the alpha-anomer of a carbocyclic abasic site
CGTACNCATGC
>pdb|1U64|B Chain B, The Solution Structure of d(G3T4G4)2
GGGTTTTGGGG
>pdb|1U64|A Chain A, The Solution Structure of d(G3T4G4)2
GGGTTTTGGGG
>pdb|1U6O|B Chain B, Mispairing of a Site-Specific Major Groove (2S,3S)-N6-(2,3,4-Trihydroxybutyl)-2-deoxyadenosyl DNA Adduct of Butadiene Diol Epoxide with Deoxyguanosine: Formation of a dA(anti)dG(anti) Pairing Interaction
CTTCTGGTCCG
>pdb|1U6O|A Chain A, Mispairing of a Site-Specific Major Groove (2S,3S)-N6-(2,3,4-Trihydroxybutyl)-2-deoxyadenosyl DNA Adduct of Butadiene Diol Epoxide with Deoxyguanosine: Formation of a dA(anti)dG(anti) Pairing Interaction
CGGACNAGAAG
>pdb|1U6N|B Chain B, Solution Structure of an Oligodeoxynucleotide Containing a Butadiene Derived N1 b-Hydroxyalkyl Adduct on Deoxyinosine in the Human N-ras Codon 61 Sequence
CTTCTTGTCCG
>pdb|1U6N|A Chain A, Solution Structure of an Oligodeoxynucleotide Containing a Butadiene Derived N1 b-Hydroxyalkyl Adduct on Deoxyinosine in the Human N-ras Codon 61 Sequence
CGGACNAGAAG
>pdb|1U6C|B Chain B, The NMR-derived solution structure of the (2S,3S)-N6-(2,3,4-trihydroxybutyl)-2'-deoxyadenosyl DNA adduct of butadiene diol epoxide
CTTCTTGTCCG
>pdb|1U6C|A Chain A, The NMR-derived solution structure of the (2S,3S)-N6-(2,3,4-trihydroxybutyl)-2'-deoxyadenosyl DNA adduct of butadiene diol epoxide
CGGACNAGAAG
>pdb|1PQQ|B Chain B, NMR Structure of a Cyclic Polyamide-DNA Complex
GCCTGTTAGCG
>pdb|1PQQ|A Chain A, NMR Structure of a Cyclic Polyamide-DNA Complex
CGCTAACAGGC
>pdb|1S40|B Chain B, SOLUTION STRUCTURE OF THE CDC13 DNA-BINDING DOMAIN COMPLEXED WITH A SINGLE-STRANDED TELOMERIC DNA 11-MER
GTGTGGGTGTG
>pdb|1QBY|B Chain B, THE SOLUTION STRUCTURE OF A BAY-REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CTTCTTGTCCG
>pdb|1SKP|B Chain B, NMR STRUCTURE OF D(GCATATGATAG)(DOT)D(CTATCATATGC): A CONSENSUS SEQUENCE FOR PROMOTERS RECOGNIZED BY SIGMA-K RNA POLYMERASE, 4 STRUCTURES
CTATCATATGC
>pdb|1SKP|A Chain A, NMR STRUCTURE OF D(GCATATGATAG)(DOT)D(CTATCATATGC): A CONSENSUS SEQUENCE FOR PROMOTERS RECOGNIZED BY SIGMA-K RNA POLYMERASE, 4 STRUCTURES
GCATATGATAG
>pdb|1FV8|A Chain A, NMR STUDY OF AN HETEROCHIRAL HAIRPIN
TATCANCGATA
>pdb|1C11|B Chain B, INTERCALATED D(TCCCGTTTCCA) DIMER, NMR, 7 STRUCTURES
TCCCGTTTCCA
>pdb|1C11|A Chain A, INTERCALATED D(TCCCGTTTCCA) DIMER, NMR, 7 STRUCTURES
TCCCGTTTCCA
>pdb|1GCC|C Chain C, SOLUTION NMR STRUCTURE OF THE COMPLEX OF GCC-BOX BINDING DOMAIN OF ATERF1 AND GCC-BOX DNA, MINIMIZED AVERAGE STRUCTURE
GCTGGCGGCTA
>pdb|1JDG|A Chain A, Solution Structure of a Trans-Opened (10S)-dA Adduct of (+)-(7S,8R,9S,10R)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a fully Complementary DNA Duplex
CGGTCACGAGG
>pdb|1I7V|A Chain A, THE SOLUTION STRUCTURE OF A BAY REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CGGACAAGAAG
>pdb|1HZ0|A Chain A, NMR STRUCTURE OF THE 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) C8-DEOXYGUANOSINE ADDUCT IN DUPLEX DNA
CCATCGCTACC
>pdb|1HX4|A Chain A, MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY
CCATCGCTACC
>pdb|1HWV|A Chain A, MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY
CCATCGCTACC
>pdb|1DL4|A Chain A, THE SOLUTION STRUCTURE OF A BAY-REGION 1S-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CGGACAAGAAG
>pdb|1CR3|A Chain A, SOLUTION CONFORMATION OF THE (+)TRANS-ANTI-BENZO[G]CHRYSENE-DA ADDUCT OPPOSITE DT IN A DNA DUPLEX
CTCTCACTTCC
>pdb|1BJH|A Chain A, HAIRPIN LOOPS CONSISTING OF SINGLE ADENINE RESIDUES CLOSED BY SHEARED A(DOT)A AND G(DOT)G PAIRS FORMED BY THE DNA TRIPLETS AAA AND GAG: SOLUTION STRUCTURE OF THE D(GTACAAAGTAC) HAIRPIN, NMR, 16 STRUCTURES
GTACAAAGTAC
>pdb|1ONM|B Chain B, Solution Structure of a DNA duplex containing A:G mismatch. d(GCTTCAGTCGT):d(ACGACGGAAGC)
ACGACGGAAGC
>pdb|1ONM|A Chain A, Solution Structure of a DNA duplex containing A:G mismatch. d(GCTTCAGTCGT):d(ACGACGGAAGC)
GCTTCAGTCGT
>pdb|1MXJ|B Chain B, NMR solution structure of benz[a]anthracene-dG in ras codon 12,2; GGCAGXTGGTG
CACCACCTGCC
>pdb|1MXJ|A Chain A, NMR solution structure of benz[a]anthracene-dG in ras codon 12,2; GGCAGXTGGTG
GGCAGGTGGTG
>pdb|1N8C|B Chain B, Solution Structure of a Cis-Opened (10R)-N6-Deoxyadenosine Adduct of (9S,10R)-(9,10)-Epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA Duplex
CCTCGTGACCG
>pdb|1N8C|A Chain A, Solution Structure of a Cis-Opened (10R)-N6-Deoxyadenosine Adduct of (9S,10R)-(9,10)-Epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA Duplex
CGGTCACGAGG
>pdb|1LVS|B Chain B, THE SOLUTION STRUCTURE OF D(G4T4G3)2
GGGGTTTTGGG
>pdb|1LVS|A Chain A, THE SOLUTION STRUCTURE OF D(G4T4G3)2
GGGGTTTTGGG
>pdb|1K29|B Chain B, Solution Structure of a DNA Duplex Containing M1G Opposite a 2 Base Pair Deletion
CATGCCGCGAT
>pdb|1K5F|B Chain B, SOLUTION STRUCTURE OF THE S-STYRENE ADDUCT IN THE RAS61 SEQUENCE
CTTCTTGTCCG
>pdb|1K5F|A Chain A, SOLUTION STRUCTURE OF THE S-STYRENE ADDUCT IN THE RAS61 SEQUENCE
CGGACNAGAAG
>pdb|1K5E|B Chain B, Solution Structure of R-styrene Adduct in the Ras61 Sequence
CTTCTTGTCCG
>pdb|1K5E|A Chain A, Solution Structure of R-styrene Adduct in the Ras61 Sequence
CGGACNAGAAG
>pdb|1KB1|B Chain B, SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6-THIOGUANINE OPPOSITE CYTOSINE
GCATGCGTACG
>pdb|1KB1|A Chain A, SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6-THIOGUANINE OPPOSITE CYTOSINE
CGTACNCATGC
>pdb|1KBM|B Chain B, SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6-THIOGUANINE OPPOSITE THYMINE
GCATGTGTACG
>pdb|1KBM|A Chain A, SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6-THIOGUANINE OPPOSITE THYMINE
CGTACNCATGC
>pdb|1K1G|B Chain B, STRUCTURAL BASIS FOR RECOGNITION OF THE INTRON BRANCH SITE RNA BY SPLICING FACTOR 1
TATACTAACAA
>pdb|1HZ0|B Chain B, NMR STRUCTURE OF THE 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) C8-DEOXYGUANOSINE ADDUCT IN DUPLEX DNA
GGTAGCGATGG
>pdb|1JDG|B Chain B, Solution Structure of a Trans-Opened (10S)-dA Adduct of (+)-(7S,8R,9S,10R)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a fully Complementary DNA Duplex
CCTCGTGACCG
>pdb|1HX4|B Chain B, MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY
GGTAGCGATGG
>pdb|1HWV|B Chain B, MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY
GGTAGCGATGG
>pdb|1I7V|B Chain B, THE SOLUTION STRUCTURE OF A BAY REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CTTCTTGTCCG
>pdb|1FYI|B Chain B, 11-MER DNA DUPLEX CONTAINING A 2'-DEOXYARISTEROMYCIN 8-OXO-GUANINE BASE PAIR
GTGACNCACTG
>pdb|1FYI|A Chain A, 11-MER DNA DUPLEX CONTAINING A 2'-DEOXYARISTEROMYCIN 8-OXO-GUANINE BASE PAIR
CAGTGNGTCAC
>pdb|1FJ5|B Chain B, TAMOXIFEN-DNA ADDUCT
GGTAGCGATGG
>pdb|1FJ5|A Chain A, TAMOXIFEN-DNA ADDUCT
CCATCGCTACC
>pdb|1CR3|B Chain B, SOLUTION CONFORMATION OF THE (+)TRANS-ANTI-BENZO[G]CHRYSENE-DA ADDUCT OPPOSITE DT IN A DNA DUPLEX
GGAAGTGAGAG
>pdb|1DL4|B Chain B, THE SOLUTION STRUCTURE OF A BAY-REGION 1S-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CTTCTTGTCCG
>pdb|1DJD|B Chain B, THE SOLUTION STRUCTURE OF A NON-BAY REGION 11R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CTTCTTGTCCG
>pdb|1DJD|A Chain A, THE SOLUTION STRUCTURE OF A NON-BAY REGION 11R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE
CGGACAAGAAG
>pdb|1GCC|B Chain B, SOLUTION NMR STRUCTURE OF THE COMPLEX OF GCC-BOX BINDING DOMAIN OF ATERF1 AND GCC-BOX DNA, MINIMIZED AVERAGE STRUCTURE
TAGCCGCCAGC
>pdb|1DSM|B Chain B, (-)-duocarmycin SA covalently linked to duplex DNA
GTCAATTAGTC
>pdb|1DSM|A Chain A, (-)-duocarmycin SA covalently linked to duplex DNA
GACTAATTGAC
>pdb|1AP1|B Chain B, THE SOLUTION NMR STRUCTURE OF AN S-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
CACCACCTGCC
>pdb|1AP1|A Chain A, THE SOLUTION NMR STRUCTURE OF AN S-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
GGCANGTGGTG
>pdb|1DSI|B Chain B, Solution structure of a duocarmycin sa-indole-alkylated dna dupleX
GTCAATTAGTC
>pdb|1DSI|A Chain A, Solution structure of a duocarmycin sa-indole-alkylated dna dupleX
GACTAATTGAC
>pdb|1A6H|B Chain B, DNA QUADRUPLEX CONTAINING GCGC TETRAD, NMR, 4 STRUCTURES
GCGGTTTGCGG
>pdb|1A6H|A Chain A, DNA QUADRUPLEX CONTAINING GCGC TETRAD, NMR, 4 STRUCTURES
GCGGTTTGCGG
>pdb|1AXV|B Chain B, SOLUTION NMR STRUCTURE OF THE [BP]DA ADDUCT OPPOSITE DT IN A DNA DUPLEX, 6 STRUCTURES
GGAAGTGAGAG
>pdb|1AXV|A Chain A, SOLUTION NMR STRUCTURE OF THE [BP]DA ADDUCT OPPOSITE DT IN A DNA DUPLEX, 6 STRUCTURES
CTCTCACTTCC
>pdb|1AXU|B Chain B, SOLUTION NMR STRUCTURE OF THE [AP]DG ADDUCT OPPOSITE DA IN A DNA DUPLEX, NMR, 9 STRUCTURES
GGTAGAGATGG
>pdb|1AXU|A Chain A, SOLUTION NMR STRUCTURE OF THE [AP]DG ADDUCT OPPOSITE DA IN A DNA DUPLEX, NMR, 9 STRUCTURES
CCATCGCTACC
>pdb|1AXL|A Chain A, SOLUTION CONFORMATION OF THE (-)-TRANS-ANTI-[BP]DG ADDUCT OPPOSITE A DELETION SITE IN DNA DUPLEX D(CCATC-[BP]G-CTACC)D(GGTAG--GATGG), NMR, 6 STRUCTURES
CCATCGCTACC
>pdb|1AGH|B Chain B, THE SOLUTION STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE DUPLEX CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, NMR, MINIMIZED AVERAGE STRUCTURE
CTTCTTGTCCG
>pdb|1AGH|A Chain A, THE SOLUTION STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE DUPLEX CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, NMR, MINIMIZED AVERAGE STRUCTURE
CGGACAAGAAG
>pdb|1DSA|B Chain B, (+)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DNA, NMR, 20 STRUCTURES
GTCAATTAGTC
>pdb|1DSA|A Chain A, (+)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DNA, NMR, 20 STRUCTURES
GACTAATTGAC
>pdb|1AGZ|B Chain B, THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CTTCTTGTCCG
>pdb|1AGZ|A Chain A, THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CGGACANGAAG
>pdb|1AGU|B Chain B, THE SOLUTION NMR STRUCTURE OF THE C10R ADDUCT OF BENZO[A]PYRENE-DIOL-EPOXIDE AT THE N6 POSITION OF ADENINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
CTTCTTGTCCG
>pdb|1AGU|A Chain A, THE SOLUTION NMR STRUCTURE OF THE C10R ADDUCT OF BENZO[A]PYRENE-DIOL-EPOXIDE AT THE N6 POSITION OF ADENINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
CGGACNAGAAG
>pdb|1AGO|B Chain B, THE SOLUTION NMR STRUCTURE OF AN (S)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CTTCTTGTCCG
>pdb|1AGO|A Chain A, THE SOLUTION NMR STRUCTURE OF AN (S)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CGGACANGAAG
>pdb|1AGK|B Chain B, THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE SECOND POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CTTCTTGTCCG
>pdb|1AGK|A Chain A, THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE SECOND POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE
CGGACNAGAAG
>pdb|1AG3|B Chain B, DUPLEX OLIGODEOXYNUCLEOTIDE CONTAINING PROPANODEOXYGUANOSINE OPPOSITE A TWO-BASE DELETION, NMR, MINIMIZED AVERAGE STRUCTURE
CATGCCGCGAT
>pdb|1AFZ|B Chain B, SOLUTION NMR STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE FROM THE HUMAN N-RAS PROTOONCOGENE ENCODING FOR AMINO ACIDS 11-13 OF P21, MINIMIZED AVERAGE STRUCTURE
CACCACCTGCC
>pdb|1AFZ|A Chain A, SOLUTION NMR STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE FROM THE HUMAN N-RAS PROTOONCOGENE ENCODING FOR AMINO ACIDS 11-13 OF P21, MINIMIZED AVERAGE STRUCTURE
GGCAGGTGGTG
>pdb|1AF1|B Chain B, THE SOLUTION NMR STRUCTURE OF AN R-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
CACCACCTGCC
>pdb|1AF1|A Chain A, THE SOLUTION NMR STRUCTURE OF AN R-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE
GGCAGNTGGTG
>pdb|1FKY|B Chain B, NMR STUDY OF B-DNA CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES
GAGCTTGTGGC
>pdb|1FKY|A Chain A, NMR STUDY OF B-DNA CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES
GCCACCAGCTC
>pdb|1KOD|A Chain A, RNA APTAMER COMPLEXED WITH CITRULLINE, NMR
NGAAGGAGTGT
>pdb|1FKZ|B Chain B, NMR STUDY OF B-DNA CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES
GAGCTCGTGGC
>pdb|1FKZ|A Chain A, NMR STUDY OF B-DNA CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES
GCCACCAGCTC
>pdb|1KOC|A Chain A, RNA APTAMER COMPLEXED WITH ARGININE, NMR
NGAAGGAGCGT
>pdb|1FJB|B Chain B, NMR Study of an 11-Mer DNA Duplex Containing 7,8-Dihydro-8-Oxoadenine (AOXO) Opposite Thymine
CGTACNCATGC
>pdb|1FJB|A Chain A, NMR Study of an 11-Mer DNA Duplex Containing 7,8-Dihydro-8-Oxoadenine (AOXO) Opposite Thymine
GCATGTGTACG
>pdb|1D69|B Chain B, SOLUTION STRUCTURE OF [D(ATGAGCGAATA)]2: ADJACENT G:A MISMATCHES STABILIZED BY CROSS-STRAND BASE-STACKING AND BII PHOSPHATE GROUPS
NTGAGCGAATA
>pdb|1D69|A Chain A, SOLUTION STRUCTURE OF [D(ATGAGCGAATA)]2: ADJACENT G:A MISMATCHES STABILIZED BY CROSS-STRAND BASE-STACKING AND BII PHOSPHATE GROUPS
NTGAGCGAATA
>pdb|1LCD|C Chain C, STRUCTURE OF THE COMPLEX OF LAC REPRESSOR HEADPIECE AND AN 11 BASE-PAIR HALF-OPERATOR DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS
CGCTCACAATT
>pdb|1LCD|B Chain B, STRUCTURE OF THE COMPLEX OF LAC REPRESSOR HEADPIECE AND AN 11 BASE-PAIR HALF-OPERATOR DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS
AATTGTGAGCG
>pdb|1LCC|C Chain C, STRUCTURE OF THE COMPLEX OF LAC REPRESSOR HEADPIECE AND AN 11 BASE-PAIR HALF-OPERATOR DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS
CGCTCACAATT
>pdb|1LCC|B Chain B, STRUCTURE OF THE COMPLEX OF LAC REPRESSOR HEADPIECE AND AN 11 BASE-PAIR HALF-OPERATOR DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS
AATTGTGAGCG
>pdb|7RDQ|I Chain I, Cryo-EM structure of Thermus thermophilus reiterative transcription complex with 11nt oligo-G RNA
NGGGGGGGGGG
>pdb|5WN0|C Chain C, APE1 exonuclease substrate complex with a C/G match
NCGACGGATCC
>pdb|7M3T|ll Chain ll, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
NTTTTTTTTTT
>pdb|7M3T|i Chain i, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
NTTTTTTTTTT
>pdb|5BKL|TT Chain TT, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAA
>pdb|5BKL|m Chain m, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NTTTTTTTTTT
>pdb|5BKL|a Chain a, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAA
>pdb|5BKL|Y Chain Y, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAA
>pdb|7MKO|R Chain R, Escherichia coli RNA polymerase elongation complex
NCGGAGAGGTA
>pdb|7MKN|R Chain R, Escherichia coli RNA polymerase and RapA elongation complex
NCGGAGAGGTA
>OF147550.1 KR 1020210005057-A/2079: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
ATGGCATTTCT
>OF147542.1 KR 1020210005057-A/2071: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
ATGGCATTTCT
>OF188102.1 KR 1020210005661-A/117: PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED AMINOPEPTIDASE N (ANPEP) GENES
AGCCAGCGTGC
>OF187837.1 KR 1020210005090-A/27: CHIMERIC VECTORS
AGGATAAGTGA
>OF187821.1 KR 1020210005090-A/11: CHIMERIC VECTORS
CTGGAAAATGT
>OF265881.1 KR 1020210042128-A/116: NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
CTAGCGCCACC
>OF263729.1 KR 1020210039421-A/406: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
AACACACAGAG
>OF263726.1 KR 1020210039421-A/403: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
ATTCAACACAC
>OF263720.1 KR 1020210039421-A/397: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
AACACACAGAG
>OF263719.1 KR 1020210039421-A/396: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
TCAACACACAG
>OF263714.1 KR 1020210039421-A/391: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
AACACACAGAG
>OF141006.1 KR 1020210053228-A/52: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTCTTTTCT
>OF141001.1 KR 1020210053228-A/47: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTCTTTCTTT
>OF140995.1 KR 1020210053228-A/41: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTCTTTTTT
>OF140988.1 KR 1020210053228-A/34: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTGTTTTGT
>OF140983.1 KR 1020210053228-A/29: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTGTTTGTTT
>OF140977.1 KR 1020210053228-A/23: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTGTTTTTT
>OF140970.1 KR 1020210053228-A/16: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTATTTTAT
>OF140965.1 KR 1020210053228-A/11: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTATTTATTT
>OF140959.1 KR 1020210053228-A/5: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTATTTTTT
>OF140238.1 KR 1020210028134-A/99: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
AAAANATAAAA
>OF140236.1 KR 1020210028134-A/97: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
TTDWTTTTTNT
>OF259564.1 KR 1020210039401-A/59: COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
TGTKTGTKTGT
>OF136068.1 KR 1020210055276-A/15: Polycistronic Expression System for Plants
GGTCTCNATAT
>OF136067.1 KR 1020210055276-A/14: Polycistronic Expression System for Plants
GGTCTCNACCC
>OF136066.1 KR 1020210055276-A/13: Polycistronic Expression System for Plants
GGTCTCNTAGC
>OF136065.1 KR 1020210055276-A/12: Polycistronic Expression System for Plants
GGTCTCNCCCT
>OF136064.1 KR 1020210055276-A/11: Polycistronic Expression System for Plants
GGTCTCNCCTC
>OF136063.1 KR 1020210055276-A/10: Polycistronic Expression System for Plants
GGTCTCNAACC
>OF293481.1 KR 1020210066947-A/13: A Fusion Protein Comprising DNA Binding Protein Containing PPR Motif
AATTTGTCGAT
>OF255019.1 KR 1020210021111-A/70: TREATMENT OF AMD USING AAV SFLT-1
GGTTCGAACAG
>OF291607.1 KR 1020210080470-A/54: SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT
GAGCTAGTTGA
>OF291570.1 KR 1020210080470-A/17: SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT
AGTGTAACAGC
>OF291568.1 KR 1020210080470-A/15: SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT
AGGGTAACAGC
>OF209797.1 KR 1020210040911-A/99: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
AAAANATAAAA
>OF288014.1 KR 1020210049986-A/6: CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
GGGATCCTACC
>OF209795.1 KR 1020210040911-A/97: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
TTDWTTTTTNT
>OF287984.1 KR 1020210069075-A/179: METHODS AND COMPOSITIONS FOR OCULAR CELL THERAPY
NNNNNNNNNGG
>OF209562.1 KR 1020210040910-A/99: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
AAAANATAAAA
>OF209560.1 KR 1020210040910-A/97: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
TTDWTTTTTNT
>OF287665.1 KR 1020210048605-A/41: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
ACGGGTAGGAC
>OF287643.1 KR 1020210048605-A/13: COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA
TTAAGAAAAAA
>OF209327.1 KR 1020210040909-A/99: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
AAAANATAAAA
>OF209325.1 KR 1020210040909-A/97: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
TTDWTTTTTNT
>OF167875.1 KR 1020210005074-A/117: METHODS FOR PROTECTING PORCINE FETUSES FROM INFECTION WITH VIRUS
AGCCAGCGTGC
>OF247443.1 KR 1020210016078-A/2301: CHIRAL CONTROL
CAGGTAAGTAT
>OF245032.1 KR 1020210018510-A/205: NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES
CTAACTGGGGA
>OF241492.1 KR 1020210013304-A/334: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>OF241491.1 KR 1020210013304-A/333: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>OF241472.1 KR 1020210013304-A/314: USING RNA-GUIDED FOKI NUCLEASES (RFNS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>OF240871.1 KR 1020210013303-A/2744: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>OF240870.1 KR 1020210013303-A/2743: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
GAAGCTGGAGG
>OF240851.1 KR 1020210013303-A/2724: USING TRUNCATED GUIDE RNAS (TRU-GRNAS) TO INCREASE SPECIFICITY FOR RNA-GUIDED GENOME EDITING
TCAACCGGTGG
>OF277386.1 KR 1020210037757-A/13: A Method for Designing a Fusion Protein Comprising DNA Binding Protein Containing PPR Motif
AATTTGTCGAT
>OF198940.1 KR 1020210010555-A/56: DRUG-RESISTANT IMMUNE CELLS AND METHODS OF USE THEREOF
AACCGTAAAAT
>OF277208.1 KR 1020210049898-A/4: PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES
CTTTCTCTCTG
>OF277085.1 KR 1020210039495-A/109: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AGCCGATAACC
>OF277084.1 KR 1020210039495-A/108: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GAAGCAGTAAT
>OF277083.1 KR 1020210039495-A/107: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTAAGGCACTT
>OF277082.1 KR 1020210039495-A/106: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GAGCCTACTTC
>OF277081.1 KR 1020210039495-A/105: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGACCTTTTA
>OF277080.1 KR 1020210039495-A/104: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CACTGTGTGTG
>OF277079.1 KR 1020210039495-A/103: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTCCACTCATG
>OF277078.1 KR 1020210039495-A/102: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCTGCCCCTCT
>OF277077.1 KR 1020210039495-A/101: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTTAATTCAG
>OF277075.1 KR 1020210039495-A/99: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TGCCGATAACC
>OF277074.1 KR 1020210039495-A/98: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GAAGCAGTAAT
>OF277073.1 KR 1020210039495-A/97: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTCTCCTGACA
>OF277072.1 KR 1020210039495-A/96: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTGTTAGTTA
>OF277071.1 KR 1020210039495-A/95: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTACAAAAA
>OF277070.1 KR 1020210039495-A/94: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCACAATTATG
>OF277069.1 KR 1020210039495-A/93: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ATGTATGAACA
>OF277068.1 KR 1020210039495-A/92: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTGGGGCTTTC
>OF277067.1 KR 1020210039495-A/91: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GGAACTTGAAG
>OF277066.1 KR 1020210039495-A/90: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTTTTTTTT
>OF277065.1 KR 1020210039495-A/89: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GCCATTGTAAA
>OF277064.1 KR 1020210039495-A/88: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ACAAACCTAAA
>OF277063.1 KR 1020210039495-A/87: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GACTTGCCTTT
>OF277062.1 KR 1020210039495-A/86: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAATCATACAG
>OF277061.1 KR 1020210039495-A/85: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTGGGGGGGG
>OF277060.1 KR 1020210039495-A/84: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCATGAAATAA
>OF277059.1 KR 1020210039495-A/83: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ATTAACATGCT
>OF277058.1 KR 1020210039495-A/82: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTAAAAAAAT
>OF277057.1 KR 1020210039495-A/81: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTACAAAAA
>OF277056.1 KR 1020210039495-A/80: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCACAATTATG
>OF277055.1 KR 1020210039495-A/79: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GATAAATCTCT
>OF277054.1 KR 1020210039495-A/78: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTCTGGCGAC
>OF277052.1 KR 1020210039495-A/76: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAATTTAGTCT
>OF277051.1 KR 1020210039495-A/75: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCAGCATAAAC
>OF277050.1 KR 1020210039495-A/74: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTAGAAAATTG
>OF277049.1 KR 1020210039495-A/73: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ATTTATACTTT
>OF277048.1 KR 1020210039495-A/72: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CATAATTTTCC
>OF277046.1 KR 1020210039495-A/70: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTCTGGCGAC
>OF277043.1 KR 1020210039495-A/67: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GCACGAATATA
>OF276985.1 KR 1020210039495-A/9: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AATATGTTTTA
>OF276983.1 KR 1020210039495-A/7: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TAATTTATTGT
>OF276982.1 KR 1020210039495-A/6: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTTTCTGTGC
>OF276979.1 KR 1020210039495-A/3: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTCCTGGCACT
>OF277042.1 KR 1020210039495-A/66: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTGATTTTG
>OF277041.1 KR 1020210039495-A/65: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTAATGAGAAG
>OF277040.1 KR 1020210039495-A/64: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CAAATTAAAAA
>OF277037.1 KR 1020210039495-A/61: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTCTTACCGAC
>OF277036.1 KR 1020210039495-A/60: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AATTTTAGGCA
>OF277035.1 KR 1020210039495-A/59: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CAAAGACATAG
>OF277034.1 KR 1020210039495-A/58: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGCCCTCCAT
>OF277033.1 KR 1020210039495-A/57: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ATTTGGTTCAC
>OF277032.1 KR 1020210039495-A/56: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CACATCACAAA
>OF277031.1 KR 1020210039495-A/55: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTATGACATAT
>OF277030.1 KR 1020210039495-A/54: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ACAAATGTAGA
>OF277029.1 KR 1020210039495-A/53: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAGTAAGAAAA
>OF277027.1 KR 1020210039495-A/51: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CAGCTGGTTCC
>OF277026.1 KR 1020210039495-A/50: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AATTTTAGGCA
>OF277025.1 KR 1020210039495-A/49: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CAAAGACATAG
>OF277024.1 KR 1020210039495-A/48: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTGGAGTGAAA
>OF277023.1 KR 1020210039495-A/47: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTCCAAAGGG
>OF277022.1 KR 1020210039495-A/46: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GATCTGTCGAT
>OF277021.1 KR 1020210039495-A/45: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CCTTCTCTTGG
>OF277020.1 KR 1020210039495-A/44: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TGGAAACTTGG
>OF277019.1 KR 1020210039495-A/43: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AACACTATGTA
>OF277018.1 KR 1020210039495-A/42: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AGTGCACTTAA
>OF277017.1 KR 1020210039495-A/41: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAACAAAAAGC
>OF277016.1 KR 1020210039495-A/40: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AGCAAAGAATA
>OF277015.1 KR 1020210039495-A/39: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTTTAATAC
>OF277014.1 KR 1020210039495-A/38: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTCTTGAAAAC
>OF277013.1 KR 1020210039495-A/37: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTGCTTTTGAA
>OF277012.1 KR 1020210039495-A/36: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGGACTCATC
>OF277011.1 KR 1020210039495-A/35: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTCTCATGGG
>OF277010.1 KR 1020210039495-A/34: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGATGCATGT
>OF277009.1 KR 1020210039495-A/33: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCTGTGAAGGA
>OF277008.1 KR 1020210039495-A/32: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CATTTTCAATA
>OF277007.1 KR 1020210039495-A/31: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAAAGAAAACA
>OF277006.1 KR 1020210039495-A/30: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTGTTAAAGAA
>OF277005.1 KR 1020210039495-A/29: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ACAATTTTGGT
>OF277004.1 KR 1020210039495-A/28: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTCAGGCAGAG
>OF277003.1 KR 1020210039495-A/27: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GAGGTTGAGAC
>OF277002.1 KR 1020210039495-A/26: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CCCTCAATAAA
>OF277001.1 KR 1020210039495-A/25: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAGAAGAAGCC
>OF277000.1 KR 1020210039495-A/24: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AAGATTGCAAA
>OF276999.1 KR 1020210039495-A/23: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTTTTTTTA
>OF276998.1 KR 1020210039495-A/22: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTCTTGAAAAC
>OF276997.1 KR 1020210039495-A/21: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTGCTTTTGAA
>OF276996.1 KR 1020210039495-A/20: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GCCTGCTCCTT
>OF276995.1 KR 1020210039495-A/19: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AGGCTTGCAGA
>OF276994.1 KR 1020210039495-A/18: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTTTTCTGTGC
>OF276992.1 KR 1020210039495-A/16: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTTGGTTGAT
>OF276990.1 KR 1020210039495-A/14: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
ATTCACATGGG
>OF276989.1 KR 1020210039495-A/13: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GGGGAAAAAAC
>OF276988.1 KR 1020210039495-A/12: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GATAAGAACAT
>OF276986.1 KR 1020210039495-A/10: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TGTGGAGCAAT
>pdb|7B4E|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R282W mutant bound to DNA and MQ: R282W-DNA-MQ
CGGGCATGCCC
>MY533148.1 Sequence 4 from patent US 11118233
CACTGCATATT
>MY533147.1 Sequence 2 from patent US 11118233
CACTGTATATT
>MY532602.1 Sequence 1 from patent US 11118219
GGCTTATGGAG
>MY532516.1 Sequence 51 from patent US 11118213
ACAGAAAGACA
>MY532427.1 Sequence 89 from patent US 11118207
TTTTTTTTTTT
>MY532403.1 Sequence 65 from patent US 11118207
AAAAAAAAAAA
>MY532269.1 Sequence 30 from patent US 11118206
ATTGTACCAGT
>MY524635.1 Sequence 435 from patent US 11118178
AACAGTGGATA
>MY516669.1 Sequence 71 from patent US 11116851
GAAAGGGGCTG
>MQ295990.1 Sequence 1220 from Patent WO2021219750
TTTTCTGAAAT
>MQ292104.1 Sequence 17 from Patent WO2021222304
GGGATCCTACC
>MQ290690.1 Sequence 52 from Patent WO2021213903
GAGTTAAAACT
>MQ281613.1 Sequence 22 from Patent WO2021215932
GGCCTTGGCCA
>MQ281549.1 Sequence 68 from Patent WO2021216853
ACAATAGGAGC
>MQ281548.1 Sequence 67 from Patent WO2021216853
ACAATAGGAGC
>MQ281547.1 Sequence 66 from Patent WO2021216853
CGTTTGGTCTC
>MQ281546.1 Sequence 65 from Patent WO2021216853
CGTTTAGTCTC
>MQ281545.1 Sequence 64 from Patent WO2021216853
CGTTTAGTCTC
>MQ281539.1 Sequence 58 from Patent WO2021216853
AATTTGTCTAG
>MQ281538.1 Sequence 57 from Patent WO2021216853
AATTTTTGGAG
>MQ281536.1 Sequence 55 from Patent WO2021216853
AGTTTTTTTTA
>MQ281522.1 Sequence 41 from Patent WO2021216853
AATTTTTGGAG
>pdb|2ZKF|D Chain D, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
CTATCNGGTGA
>pdb|2ZKF|C Chain C, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
NACCGGATAGA
>pdb|2Z3X|E Chain E, Structure of a Protein-DNA Complex Essential for DNA Protection in Spore of Bacillus Species
CCCCCCCCCCA
>pdb|2Z3X|D Chain D, Structure of a Protein-DNA Complex Essential for DNA Protection in Spore of Bacillus Species
GGGGGGGGGGA
>pdb|2DPU|E Chain E, Crystal structure of the replication termination protein in complex with a pseudosymmetric 21mer B-site DNA
CTATGAACATT
>pdb|1YZ9|F Chain F, Crystal structure of RNase III mutant E110Q from Aquifex aeolicus complexed with double stranded RNA at 2.1-Angstrom Resolution
CGAACTTCGCG
>pdb|1YZ9|E Chain E, Crystal structure of RNase III mutant E110Q from Aquifex aeolicus complexed with double stranded RNA at 2.1-Angstrom Resolution
CGAACTTCGCG
>pdb|1YZ9|D Chain D, Crystal structure of RNase III mutant E110Q from Aquifex aeolicus complexed with double stranded RNA at 2.1-Angstrom Resolution
CGAACTTCGCG
>pdb|1YZ9|C Chain C, Crystal structure of RNase III mutant E110Q from Aquifex aeolicus complexed with double stranded RNA at 2.1-Angstrom Resolution
CGAACTTCGCG
